Item 9A. Controls and Procedures
Item 9A
- Controls and Procedures
Our
management, with the participation of our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal
Financial Officer and Principal Accounting Officer), evaluated the effectiveness of our disclosure controls and procedures pursuant to
Rules 13a-15(e) and 15d-15(e) under the Exchange Act. In designing and evaluating the disclosure controls and procedures, management
recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving
the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource
constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative
to their costs.
Based on management’s evaluation, our Chief
Executive Officer and Chief Financial Officer concluded that, as a result of the material weaknesses described below, as of December 31,
2022, our disclosure controls and procedures are not designed at a reasonable assurance level and are ineffective to provide reasonable
assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed,
summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated
to our management, including our Chief Executive Officer, as appropriate, to allow timely decisions regarding required disclosure. The
material weaknesses, which relate to internal control over financial reporting, that were identified include the following: We did not
have enough personnel in our accounting and financial reporting functions. Due to insufficient personnel in our accounting department,
we were not able to achieve adequate segregation of duties, and, as a result, we did not have adequate review controls surrounding: (i)
our technical accounting matters in our financial reporting process, and (ii) the work of specialists involved in the estimation process.
These control deficiencies, which are pervasive in nature, result in a reasonable possibility that material misstatements of the financial
statements will not be prevented or detected on a timely basis. Management believes that the hiring of additional personnel who have the
technical expertise and knowledge with the non-routine or technical issues we have encountered in the past will result in both proper
recording of these transactions and a much more knowledgeable finance department as a whole. Since our assessment as of December 31, 2022,
we have hired additional external accounting staff, whom are consultants with expertise in research and technical guidance, and we are
working to retain additional qualified valuation experts that report on their internal controls. We believe that these additions may provide
for the remediation of these material weaknesses in 2023.
We
will continue to monitor and evaluate the effectiveness of our disclosure controls and procedures and our internal controls over financial
reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as
necessary and as funds allow.
Changes in internal control
over financial reporting.
There
were no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d)
of Rule 13a-15 or 15d-15 under the Exchange Act that occurred during the fourth quarter ended December 31, 2022 that have materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Since our assessment as of December 31, 2022,
we have hired additional external accounting staff, whom are consultants with expertise in research and technical guidance. We believe
that these additions may provide for the remediation of our material weaknesses in 2023.
Management’s report
on internal control over financial reporting.
Our
Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Exchange
Act Rule 13a-15(f). Management conducted an evaluation of the effectiveness of our internal control over financial reporting based
on the framework in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway
Commission. Based on this evaluation, management concluded that our internal control over financial reporting was not effective as of
December 31, 2022 for the reasons discussed above.
32
Item 9B
- Other Information
None.
Item 9C
- Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Not
applicable.
33
PART
III
Item 10
- Directors, Executive Officers and Corporate Governance
Directors
and Executive Officers
The
following table sets forth information about our directors, executive officers and significant employees.
Name
Age
Position(s)
James
Ballengee
57
Chief
Executive Officer (Principal Executive Officer) and Director
Tyler
Nelson
42
Chief
Financial Officer (Principal Financial Officer and Principal Accounting Officer) and Director
Dr.
Daniel Hashim
38
Chief
Scientific Officer
John
Harris
74
Director
Albert
Johnson
48
Director
David
Natan
69
Director
Executive
Officers
James
H. Ballengee joined Vivakor as Chief Executive Officer and Chairman of the Board in 2022. Prior to joining the Company, Mr. Ballengee
had more than two decades of experience in midstream oil and gas senior management roles. Previously, he had been involved in two major
private equity portfolio companies holding positions including Chief Commercial Officer, Chief Financial Officer, Chief Executive Officer,
and Chairman of the Board. From 1997 through 2010, Mr. Ballengee served first as Chief Financial Officer, then Chief Executive Officer,
then Chief Commercial Officer of Taylor Logistics, LLC, a Halifax Group-backed private equity portfolio company focused on crude oil
marketing and logistics, which he led through a successful sale to Gibson Energy, Inc. (TSX: GEI). From 2010 to 2013, he was Chief Executive
Officer and Chairman of the Board of Bridger Group, LLC, a private crude oil marketing firm. From 2013 to 2015, he was a board member
and Chief Commercial Officer of Bridger, LLC, a Riverstone Holdings-backed private equity portfolio company focused on crude oil marketing
and logistics, which he led through a successful sale to Ferrellgas Partners, LP (NYSE: FGP). Mr. Ballengee currently manages an exempt
family office, which in turn holds and manages investments principally in the oil and gas, sports and entertainment, and real estate
sectors. He has an undergraduate degree in accounting from Louisiana State University—Shreveport.
Tyler
Nelson joined Vivakor on a part-time basis as Chief Financial Officer in 2014 and has served as full-time Chief Financial Officer
since September 2020. Mr. Nelson joined the Board of Directors of Vivakor in January 2023. Mr. Nelson is a CPA who worked from
2006 to 2011 in Audit and Enterprise Risk Services at Deloitte LLP (USA) and later at Withum+Brown, PC. He worked with clients with assets
of more than $100 billion and annual revenues of more than $15 billion, which are considered some of the most respected financial institutions
in the world. In 2011, Mr. Nelson began working for LBL Professional Consulting, Inc. where he provided merger and acquisition, initial
public offering, and interim chief financial officer services to clients. Mr. Nelson continues to sit on the Board of Directors and remains
an officer of LBL Professional Consulting, Inc. Mr. Nelson earned a Master’s Degree in Accountancy from the University of Illinois-
Urbana-Champaign, and a Bachelor’s Degree in Economics with a minor in Business Management from Brigham Young University.
Dr.
Daniel Hashim joined Vivakor as Chief Scientific Officer in 2017. Dr. Hashim has extensive experience in the areas of nanoscience
research, advanced materials synthesis, characterization, application, innovation and technological entrepreneurship. In addition to
leading scientific efforts for Vivakor and its related companies, Dr. Hashim has served as the Founder, Chairman and CEO of CSS Nanotech,
Inc. (“CSS”) since 2014. CSS is a nanomaterials research and development company that designs and commercializes useful structural
nanomaterials that exhibit “safe-to-handle” nanofunctionality on a macro-scale, to include carbon filtration media, water
purification, oil spill remediation, structural composite materials, electrode materials, petrochemical refining and thermal management
systems. Mr. Hashim holds a Bachelor’s Degree in Materials Science Engineering from Rensselaer Polytechnic Institute, with a PhD
from Rice University in the field of Materials Science and NanoEngineering.
34
Directors
James
Ballengee - See “Executive Officers”
Tyler
Nelson - See “Executive Officers”
John
R. Harris , age 74, combines over 35 years of experience in Board of Directors, CEO and Senior Management positions in a variety of
industries including technology services, telecommunications, healthcare, and business process outsourcing. He currently serves on the
board of directors for the Hackett Group, Hifu Prostate Services, GenHemp, and Everservice. Since 2009 Mr. Harris has primarily been
a private investor, advisor, and board member for both public and privately held companies. From 2006 to 2009 he was CEO of Etelecare
Global solutions a leading provider of offshore teleservices to Fortune 1,000 companies. From 2003 to 2005 he served as the CEO of Seven
Worldwide, a digital content management company where he was previously a member of the board of directors of the company. From 2001
to 2003, Mr. Harris consulted with a variety of venture-backed early-stage companies. Previously Mr. Harris spent 25 years with Electronic
Data Systems in a variety of senior executive positions to include President of the 4 strategic business units serving the telecommunications
and media industries world-wide. He was elected as a Corporate Vice-President and Officer of the company. During his tenure with EDS,
he gained extensive international experience working and living in the Middle East, Europe and Asia. Mr. Harris has extensive public
company board experience through prior services on the boards of Premier Global Services, Cap Rock Communications, Genuity, Ventiv Health,
Startek, Sizmek, Mobivity and Applied Graphic Technologies and served in a variety of positions to include board member, committee chairman,
lead director and chairman. Mr. Harris received his BBA and MBA from the University of West Georgia where he serves on the Board of Advisors
to the Richards School of Business.
Albert
Johnson , age 48, brings over 25 years of experience in operations and senior management in the midstream and downstream sectors of
the oil and gas industry. Previously, Mr. Johnson had been involved in public and privately held companies holding various positions
in senior management and serving as a member of boards of directors. From 2014 to 2015, he was Director of Business Development for Sunoco
Logistics, LP., a publicly traded master limited partnership involved in the marketing, trading, transportation and terminalling of crude
oil, products and NGLS. From July 2015 through May 2017, Mr. Johnson was the Vice President of Business Development for Navigator
Energy Services, LLC., a private equity backed company involved in the gathering, transportation and terminalling of crude oil. From
March 2018 to November 2022, Mr. Johnson served as Executive Vice President Business Development for ARX Energy, LLC. Since
November 2022, Mr. Johnson has served as Chief Commercial Officer for ARX Energy, LLC., a privately held company involved in building
a world class clean fuels facility in the Port of Brownsville, Texas. Mr. Johnson served on the Board of Directors for West Texas Gulf
Pipe Line Company and on the Management Committee of SunVit Pipeline, LLC. He has an undergraduate degree in History from the University
of Texas at Austin and an MBA finance concentration from Jones Graduate School of Business at Rice University.
David
Natan , age 69, currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering
chief financial officer services to public and private companies in a variety of industries, since 2007. In addition, Mr. Natan currently
serves as Executive Vice President and Chief Financial Officer for Airborne Motorworks, Inc., a privately-held aerospace transportation
company, since April 2020. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy,
Inc. (OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007,
Mr. Natan served as Executive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development
services company, and, from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations,
Inc., a manufacturer and marketer of oil analysis instruments and speakers and speaker components. Prior to that, Mr. Natan served in
various roles of increasing responsibility with Deloitte & Touche LLP, a global consulting firm. Mr. Natan currently serves as a
member of the Board of Directors and Chair of the Audit Committee of Global Diversified Marketing Group, Inc. (OTCMKTS: GDMK), a manufacturer,
marketer and distributor of food and snack products, since February 2021 and serves as a member of the Board of Directors and Chair
of the Audit Committee of Sunshine Biopharma, Inc. (NASDAQ: SBFM), a pharmaceutical and nutritional supplement company, since February 2022.
Previously, Mr. Natan served as Chairman of the Board of Directors of ForceField Energy, Inc., from April 2015 to May 2020,
and as a member of the Board of Directors of Global Technovations, Inc., from December 1999 to December 2001. Mr. Natan holds
a B.A. in Economics from Boston University.
Family
Relationships
There
are no family relationships between any of our directors and executive officers.
35
Corporate
Governance Overview
Board
Composition and Director Independence
Our Board of Directors consists of five members.
The directors are elected at each annual meeting to hold office until the next annual meeting and until their successors are duly elected
and qualified. The Company defines “independent” as that term is defined in the Nasdaq rules.
In
making the determination of whether a member of the board is independent, our board considers, in addition to Nasdaq rules, among other
things, and transactions and relationships between each director and his immediate family and the Company, including those reported under
the caption “Related Party Transactions.” The purpose of this review is to determine whether any such relationships or transactions
are material and, therefore, inconsistent with a determination that the directors are independent. On the basis of such review and its
understanding of such relationships and transactions, our Board of Directors affirmatively determined that David Natan, Matthew Balk
and Trent Staggs are qualified as independent and do not have any material relationships with us that might interfere with his exercise
of independent judgment.
Board
Committees
Our
Board of Directors has established an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee.
Each committee has its own charter, which is available on our website at www.vivakor.com . Each of the board committees has the
composition and responsibilities described below.
Members
will serve on these committees until their resignation or until otherwise determined by our Board of Directors.
Audit
Committee
Our
Audit Committee is currently comprised of David Natan, Albert Johnson and John Harris, each of whom qualify as an independent director
under applicable Nasdaq and SEC rules, and “financially literate” under applicable Nasdaq rules. Our board has determined
that David Natan, qualifies as an “audit committee financial expert”, as such term is defined in Item 407(d)(5) of Regulation
S-K. David Natan serves as the chairman of the Audit Committee.
The
Audit Committee oversees our accounting and financial reporting processes and oversee the audit of our consolidated financial statements
and the effectiveness of our internal control over financial reporting. The responsibilities of this committee include, but are not limited
to:
●
selecting
and recommending to our Board of Directors the appointment of an independent registered public
accounting firm and overseeing the engagement of such firm;
●
approving
the fees to be paid to the independent registered public accounting firm;
●
helping
to ensure the independence of the independent registered public accounting firm;
●
overseeing
the integrity of our financial statements;
●
preparing
an audit committee report as required by the SEC to be included in our annual proxy statement;
●
resolving
any disagreements between management and the auditors regarding financial reporting;
●
reviewing
with management and the independent auditors any correspondence with regulators and any published
reports that raise material issues regarding the Company’s accounting policies;
●
reviewing
and approving all related-party transactions; and
●
overseeing
compliance with legal and regulatory requirements.
36
The
Audit Committee is authorized to retain independent legal and other advisors and conduct or authorize investigations into any matter
within the scope of its duties.
Compensation
Committee
Our Compensation Committee is currently comprised
of David Natan, Albert Johnson, and John Harris, each of whom qualify as an independent director under applicable Nasdaq rules. John Harris
serves as the chairman of the Compensation Committee.
Our
Compensation Committee assists the board of directors in the discharge of its responsibilities relating to the compensation of the board
of directors and our executive officers.
The
responsibilities of this committee include, but are not limited to:
●
reviewing
and approving on an annual basis the corporate goals and objectives with respect to compensation
for our Chief Executive Officer;
●
reviewing,
approving and recommending to our board of directors on an annual basis the evaluation process
and compensation structure for our other executive officers;
●
determining
the need for and the appropriateness of employment agreements and change in control agreements
for each of our executive officers and any other officers recommended by the Chief Executive
Officer or Board of Directors;
●
providing
oversight of management’s decisions concerning the performance and compensation of
other company officers, employees, consultants and advisors;
●
reviewing
our incentive compensation and other equity-based plans and recommending changes in such
plans to our Board of Directors as needed, and exercising all the authority of our Board
of Directors with respect to the administration of such plans;
●
reviewing
and recommending to our Board of Directors the compensation of independent directors, including
incentive and equity-based compensation; and
●
selecting,
retaining and terminating such compensation consultants, outside counsel or other advisors
as it deems necessary or appropriate.
The
Compensation Committee may delegate any of its responsibilities to subcommittees as it deems appropriate. The Compensation Committee
is authorized to retain independent legal and other advisors, and conduct or authorize investigations into any matter within the scope
of its duties.
Nominating
and Corporate Governance Committee
Our Nominating and Corporate Governance Committee
is currently comprised of David Natan, Albert Johnson, and John Harris, each of whom qualify as an independent director under applicable
Nasdaq rules. Albert Johnson serves as the chairman of the Nominating and Corporate Governance Committee.
The
purpose of the Nominating and Corporate Governance Committee is to recommend to the Board of Directors nominees for election as directors
and persons to be elected to fill any vacancies on the Board of Directors, develop and recommend a set of corporate governance principles
and oversee the performance of the Board of Directors.
37
The
responsibilities of this committee include, but are not limited to:
●
recommending
to the Board of Directors nominees for election as directors at any meeting of stockholders
and nominees to fill vacancies on the board;
●
considering
candidates proposed by stockholders in accordance with the requirements in the Committee charter;
●
overseeing
the administration of the Company’s code of business conduct and ethics;
●
reviewing
with the entire Board of Directors, on an annual basis, the requisite skills and criteria
for board candidates and the composition of the board as a whole;
●
the
authority to retain search firms to assist in identifying board candidates, approve the terms
of the search firm’s engagement, and cause the Company to pay the engaged search firm’s
engagement fee;
●
recommending
to the Board of Directors on an annual basis the directors to be appointed to each committee
of the Board of Directors;
●
overseeing
an annual self-evaluation of the Board of Directors and its committees to determine whether
it and its committees are functioning effectively; and
●
developing
and recommending to the board a set of corporate governance guidelines applicable to the Company.
The
Nominating and Corporate Governance Committee may delegate any of its responsibilities to subcommittees as it deems appropriate. The
Nominating and Corporate Governance Committee is authorized to retain independent legal and other advisors and conduct or authorize investigations
into any matter within the scope of its duties.
Board
Leadership Structure
Currently,
Mr. Ballengee is our principal executive officer and chairman of the board.
Risk
Oversight
Our
Board will oversee a company-wide approach to risk management. Our Board will determine the appropriate risk level for us generally,
assess the specific risks faced by us and review the steps taken by management to manage those risks. While our Board will have ultimate
oversight responsibility for the risk management process, its committees will oversee risk in certain specified areas.
Specifically,
our compensation committee will be responsible for overseeing the management of risks relating to our executive compensation plans and
arrangements, and the incentives created by the compensation awards it administers. Our audit committee will oversee management of enterprise
risks and financial risks, as well as potential conflicts of interests. Our board of directors will be responsible for overseeing the
management of risks associated with the independence of our Board.
Code
of Business Conduct and Ethics
We
have adopted a code of business conduct and ethics applicable to our principal executive, financial and accounting officers and all persons
performing similar functions. A copy of that code is available on our corporate website at www.vivakor.com . We expect that any
amendments to such code, or any waivers of its requirements, will be disclosed on our website.
38
Item 11
- Executive Compensation
Summary
Compensation Table
The
particulars of compensation paid to the following persons:
(a)
all
individuals serving as our principal executive officer during the year ended December 31, 2022;
(b)
each
of our two most highly compensated executive officers other than our principal executive officer who were serving as executive officers
at December 31, 2022 who had total compensation exceeding $100,000 (if applicable); and
(c)
up
to two additional individuals for whom disclosure would have been provided under (b) but for the fact that the individual was not
serving as our executive officer at December 31, 2022 (if applicable),
who
we will collectively refer to as the named executive officers, for the years ended December 31, 2022 and 2021, are set out in the
following summary compensation table:
Executive
Officers and Directors
The
Summary Compensation Table shows certain compensation information for services rendered in all capacities for the fiscal years ended
December 31, 2022 and 2021. Other than as set forth herein, no executive officer’s salary and bonus exceeded $100,000 in any
of the applicable years. The following information includes the dollar value of base salaries, bonus awards, the estimated fair value
of stock options granted and certain other compensation, if any, whether paid or deferred.
SUMMARY
COMPENSATION TABLE
Name
and Principal Position
Year
Salary
($)
Bonus
($)
Stock
Awards
($)
Option
Awards
($)
Non-Equity
Incentive
Plan
Compensation
($)
Nonqualified
Deferred
Compensation
Earnings
($)
All
Other
Compensation
($)
Total
($)
James
Ballengee
2022
178,082 (2)
-0-
-0-
-0-
-0-
-0-
-0-
178,082 (2)
CEO
and Chairman (1)
Tyler
Nelson
2022
219,315 (3)
605,467
-0-
1,652,085 (4)
-0-
-0-
35,220 (5)
2,512,087
CFO
and Secretary
2021
49,920
-0-
-0-
-0-
-0-
-0-
49,920
Matthew
Nicosia
2022
138,904 (7)
125,000 (8)
-0-
1,053,224 (9)
-0-
-0-
11,044 (5)
1,328,172
Former
CEO and Former Chairman (6)
2021
50,000
-0-
-0-
-0-
-0-
-0-
-0-
50,000
(1)
Mr. Ballengee was hired as our Chief Executive Officer on October 28, 2022.
(2)
Total amount accrued as of December 31, 2022. Mr. Ballengee’s salary will be paid in shares of our common stock, priced based on the volume-weighted average price for the preceding five (5) NASDAQ trading days prior to the Effective Date or annual anniversary of his Employment Agreement, as applicable. The five (5) day volume-weighted average price of our common stock for the salary set forth in the table was $1.083. As a result, we are required to issue Mr. Ballengee 164,434 shares of our common stock as payment for his salary for 2022.
(3)
Of this total amount, $51,662 was paid in cash and the remaining $167,653 was accrued as of December 31, 2022.
39
(4)
Includes the aggregate grant date fair value of the stock option to acquire 917,825 shares of our common stock issued to Mr. Nelson under the Nelson Employment Agreement. Such stock options were priced using the Black-Scholes option pricing model to determine the fair value of the options on the date of grant, using the following assumptions:
June
9, 2022
Risk-free
interest rate
3.04%
Expected
dividend yield
None
Expected
life of warrants
10
years
Expected
volatility rate
254%
(5)
Includes amounts for accrued employee benefits. All amounts accrued as of December 31, 2022.
(6)
Mr. Nicosia resigned as an executive officer, Chairman of the Board and as a Director, effective October 6, 2022. Such resignations were not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
(7)
Of this total amount, $50,000 was paid in cash and the remaining $88,904 was accrued as of December 31, 2022.
(8)
Accrued as of December 31, 2022.
(9)
Includes the aggregate grant date fair value of the stock option to acquire 503,935 shares of our common stock issued to Mr. Nicosia under the Nicosia Employment Agreement. Stock options to acquire the remaining 451,158 shares of our common stock under the Nicosia Employment Agreement were forfeited when Mr. Nicosia resigned as our Chief Executive Officer and, as a result, have not be valued in the table. The 503,935 stock options were priced using guidance from ASC 718 and the Black-Scholes option pricing model to determine the fair value of the options on the date of grant, using the following assumptions:
June
9, 2022
Risk-free
interest rate
3.07 %
Expected
dividend yield
None
Expected
life of warrants
5
years
Expected
volatility rate
169%
Employment
Agreements
James
Ballengee
On
October 28, 2022, we entered into an executive employment agreement with James Ballengee (the “Ballengee Employment Agreement”)
with respect to our appointment of Mr. Ballengee as Chief Executive Officer and Chairman of the Board of Directors. Pursuant to the Ballengee
Employment Agreement, Mr. Ballengee will receive annual compensation of $1,000,000 payable in shares of our common stock, priced at the
volume weighted average price (VWAP) for the five trading days preceding the date of the Ballengee Employment Agreement and each anniversary
thereof (the “CEO Compensation”). The CEO Compensation is subject to satisfaction of Nasdaq rules, the provisions of our
equity incentive plan and other applicable requirements and shall be accrued if such issuance is due prior to satisfaction of such requirements.
Additionally, Mr. Ballengee shall be eligible for a discretionary performance bonus. The Ballengee Employment Agreement may be terminated
by either party for any or no reason, by providing a five days’ notice of termination.
Pursuant
to the Ballengee Employment Agreement, Mr. Ballengee was granted the right to nominate two additional directors for appointment to the
Board in his sole discretion, as well as a third additional director upon issuance of the Note Payment Shares (defined below), subject
to such directors passing a background check. Pursuant to the Ballengee Employment Agreement, Mr. Ballengee nominated John Harris and
Albert Johnson as Board of Director appointees and both were appointed in January 2023.
40
Tyler
Nelson
On
June 9, 2022, we entered into an Executive Employment Agreement with Tyler Nelson (the “Nelson Employment Agreement”)
to serve as our Chief Financial Officer. The agreement provides for an annual salary of $350,000 (the “Nelson Base Salary”).
The Nelson Base Salary is payable in equal installments and will be paid every two weeks. The Nelson Base Salary will increase by $100,000
upon the Company earning a total of at least $2,000,000 in Adjusted EBITDA during any calendar year, and the Nelson Base Salary will
continue to increase in $100,000 increments for each additional $1,000,000 increase in EBITDA over $2,000,000 during the term of the
Nelson Employment Agreement up to $650,000 at which time the Nelson Base Salary will continue to increase in $13,500 increments for each
additional $1,000,000 increase in Adjusted EBITDA over $4,000,000. Any increase to the Nelson Base Salary will be effective the first
pay period of the Company after the Company reaches a particular EBITDA amount is achieved that triggers the increase. For example purposes
only and not by way of limitation: (i) if on October 31, 2023 the Company reaches $3,000,000 in EBITDA earned during the 2023 calendar
year, the Nelson Base Salary would increase to $550,000 commencing the Company’s first pay period after October 31, 2023.
Under the Nelson Employment Agreement Mr. Nelson will also receive a $100,000 cash bonus in recognition of the fact Mr. Nelson was undercompensated
for his past services to the Company and as an inducement for him to continue providing services as our Chief Financial Officer.
The
Nelson Employment Agreement has an initial term of two years and automatically extends for successive one-year periods unless terminated
in writing by the Company or Mr. Nelson at least three months prior to the end of the applicable term. It is anticipated that Mr. Nelson
will receive a bonus for 2022, with such bonus to be determined by our Compensation Committee and Board of Directors taking into account
the general business performance of the Company, including any completed financings and/or acquisition. For 2023 forward it is anticipated
that our Compensation Committee and Board of Directors will approve an annual executive incentive bonus plan, which shall be updated
annually by the Compensation Committee of the Company’s Board of Directors, and possibly a growth metrics or acquisition transaction
bonus plan. Once established, Mr. Nelson will be eligible to participate in such plans during the term of the Nelson Employment Agreement.
Under
the Nelson Employment Agreement, Mr. Nelson was granted a stock option to acquire 917,825 shares of our common stock (the “Stock
Option”) under our 2022 Equity Incentive Plan (each an “Equity Award”). Any Equity Awards granted to Mr. Nelson will
be documented by issuing him a grant document (i.e. a stock option agreement). The Stock Option will vest over two years with 360,145
of the shares vesting immediately, 219,312 of the shares vesting three (3) months after issuance, and the remaining 338,368 of the shares
vesting in equal quarterly installments over the remaining seven (7) quarters (48,338 for 6 quarters and 48,340 for the last quarter),
with an exercise price equal to 100% of the fair market value on the date grant, and which expires ten (10) years after the date of grant.
In the event Mr. Nelson is terminated without Cause (as defined in the Nelson Employment Agreement) or resigns for Good Reason (as defined
in Nelson Employment Agreement), one hundred percent (100%) of the then unvested shares subject to each Option Agreement will fully vest
and become fully exercisable. The Option Agreement will allow Mr. Nelson to exercise the vested options provided by the Option Agreement
for a period of three (3) years following any termination of Mr. Nelson’s employment.
Upon
termination Mr. Nelson’s employment by Mr. Nelson for good reason, by the Company without cause, or by the Company because of disability,
the Company will pay or provide Mr. Nelson (i) any unpaid base salary and any accrued benefits through the date of termination; (ii)
amounts payable under any Company bonus plans in which Mr. Nelson is eligible to participate as of the date of the termination of his
employment on a pro-rated basis; (iii) for a period of 12 months, Mr. Nelson’s then current monthly base salary; (iv) outplacement
services for Mr. Nelson for a period of 12 months with an outplacement firm selected by Mr. Nelson; (v) at Mr. Nelson’s election
to continue health insurance coverage under COBRA, Mr. Nelson’s monthly premium until (a) the close of the severance period, as
defined therein, (b) the expiration of Mr. Nelson’s continuation of coverage under COBRA, or (c) the date when Mr. Nelson becomes
eligible for substantially equivalent health insurance coverage in connection with new employment, and (vi) 100% of any unvested stock
options will fully vest and become exercisable. Mr. Nelson will have three (3) after termination to exercise any vested stock options.
Upon the termination of Mr. Nelson’s employment because of death, Mr. Nelson’s estate will be entitled to receive (i) Mr.
Nelson’s then current base salary through the end of the month in which his death occurs, (ii) all accrued and unpaid compensation
(including any accrued and unused vacation time) and earned but unpaid bonus payments. Upon the termination Mr. Nelson’s employment
by the Company for cause or by Mr. Nelson without good reason, the Company will pay Mr. Nelson (i) a pro rata amount of Mr. Nelson’s
then current base salary through the date his employment is terminated and (ii) all unpaid bonuses and accrued and unpaid compensations
(including any accrued and unused vacation).
41
Stock
Incentive Plan
Equity
Incentive Plan
Our
Board of directors approved a new equity incentive plan in February 2022, which authorizes the issuance of up to 2,000,000 shares
of common stock through the grant of stock options (including incentive stock options qualifying under section 422 of the Code and
nonstatutory stock options), restricted stock awards, stock appreciation rights, restricted stock units, performance awards, other stock-based
awards or any combination of the foregoing.
Outstanding
Equity Awards at December 31, 2022
The
following table sets forth certain information concerning outstanding stock awards held by the Named Executive Officers on December 31,
2022:
Option
Awards
Stock
Awards
Name
Number
of Securities Underlying Unexercised Options
(#)
Exercisable
Number
of Securities Underlying Unexercised Options
(#)
Unexercisable
Equity
Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options
(#)
Option
Exercise Price
($)
Option
Expiration Date
Number
of Shares or Units of Stock That Have Not Vested
(#)
Market
Value of Shares or Units of Stock That Have Not Vested
($)
Equity
Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested
(#)
Equity
Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That
Have Not Vested
($)
James
Ballengee
-0-
-0-
-0-
N/A
N/A
-0-
-0-
-0-
-0-
Tyler
Nelson
627,795
290,030
-0-
1.80
June 8, 2032
-0-
-0-
-0-
-0-
Matthew
Nicosia (1)
503,935
-0-
-0-
1.98
June 8, 2027
-0-
-0-
-0-
-0-
(1) Mr.
Nicosia resigned as an executive officer, Chairman of the Board and as a Director, effective October 6, 2022. Such resignations
were not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Includes stock option to acquire 503,935 shares of our common stock issued to Mr. Nicosia under the Nicosia Employment Agreement. Stock
options to acquire the remaining 451,158 shares of our common stock under the Nicosia Employment Agreement were forfeited when Mr. Nicosia
resigned as our Chief Executive Officer and, as a result, are not reflected in the table.
Aggregated
Option Exercises
There
were no options exercised by any officer or director of our company during our twelve-month period ended December 31, 2022.
Employee
Pension, Profit Sharing or other Retirement Plan
We
do not have a defined benefit, pension plan, profit sharing or other retirement plan, although we may adopt one or more of such plans
in the future.
42
Director
Compensation
The
table below shows the compensation paid to our directors during the year ended December 31, 2022. The following current Board of
Directors members were appointed after January 1, 2023, and, as a result, are not reflected in the below table: Tyler Nelson, John
Harris and Albert Johnson.
Name
Fees
Earned or
Paid in Cash
($)
Stock
Awards
($)
Option
Awards
($)
Non-Equity
Incentive Plan Compensation
($)
Nonqualified
Deferred
Compensation
Earnings
($)
All
Other
Compensation
($)
Total
($)
James Ballengee
-
-
-
-
David Natan
1,923
-
-
-
-
1,923
Matthew Balk (1)
32,500
-
93,000
-
-
-
125,500
Trent Staggs (2)
42,500
-
93,000
-
-
-
135,500
Al Ferrara (3)
38,333
-
93,000
-
-
-
131,333
Matthew Nicosia (4)
-
-
-
-
-
-
Joseph Spence (5)
6,000
-
-
-
-
6,000
(1)
Matthew
Balk resigned from the Board of Directors on January 16, 2023.
(2)
Trent
Staggs resigned from the Board of Directors on January 4, 2023.
(3)
Al
Ferrara resigned from the Board of Directors on November 28, 2022.
(4)
Matthew
Nicosia resigned from the Board of Directors on October 6, 2022.
(5)
Joseph
Spence resigned from the Board of Directors on July 1, 2022.
Item 12
- Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
The
following table sets forth certain information regarding our voting shares beneficially owned as of May 5, 2023 by (i) each stockholder
known to be the beneficial owner of 5% or more of the outstanding shares of the particular class of voting stock, (ii) each executive
officer, (iii) each director, and (iv) all executive officers and directors as a group. A person is considered to beneficially own any
shares: (i) over which such person, directly or indirectly, exercises sole or shared voting or investment power, or (ii) of which such
person has the right to acquire beneficial ownership at any time within 60 days through an exercise of stock options, warrants and/or
other convertible securities. Unless otherwise indicated, voting and investment power relating to the shares shown in the tables for
each beneficial owner is exercised solely by the beneficial owner.
For
purposes of computing the percentage of outstanding shares of our common stock held by each person or group of persons, any shares that
such person or persons has the right to acquire within 60 days of May 5, 2023 is deemed to be outstanding, but is not deemed
to be outstanding for the purpose of computing the percentage ownership of any other person.
The
percentage of beneficial ownership of our common stock is based on an aggregate of 18,064,838 shares outstanding.
Except
as indicated in footnotes to this table, we believe that the stockholders named in this table have sole voting and investment power with
respect to all shares of common stock shown to be beneficially owned by them, based on information provided to us by such stockholders.
Unless otherwise indicated, the address for each director and executive officer listed is: c/o Vivakor, Inc., 4101 North Thanksgiving
Way, Lehi, Utah 84043.
43
Name and Address of Beneficial Owner
Shares of
Common Stock
Beneficially
Owned
Percentage
of Common
Stock
Beneficially
Owned
James H. Ballengee, Chief Executive Officer and Director (1)
3,009,552
16.66 %
Tyler Nelson, Chief Financial Officer (2)
-
*
Daniel Hashim, Chief Scientific Officer (3)
166,667
*
David Natan, Director
-
*
John R. Harris, Director
-
*
Albert Johnson, Director
-
*
All Officers and Directors as a group (six persons)
3,176,219
17.58 %
5% Beneficial Stockholders
Matthew Nicosia (4)
4,189,405
23.19 %
Everett Monroe (5)
-
-
Daniel O. Ritt Trust (6)
-
-
Peter D’Arruda (7)
-
-
Name and Address of Beneficial Owner
Value of
Class B
Units of
VV RII
Beneficially
Owned
Percentage
of VV RII
Class B
Units
Beneficially
Owned
James H. Ballengee, Chief Executive Officer and Director (1)
-
-
Tyler Nelson, Chief Financial Officer (2)
-
Daniel Hashim, Chief Scientific Officer (3)
-
-
David Natan, Director
-
-
John R. Harris, Director
-
-
Albert Johnson, Director
-
-
All Officers and Directors as a group (six persons)
-
5% Beneficial Stockholders
-
Matthew Nicosia (4)
-
-
Everett Monroe (5)
$ 90,000
7.88 %
Daniel O. Ritt Trust (6)
$ 65,000
5.69 %
Peter D’Arruda (7)
$ 60,000
5.25 %
*
Less
than 1%
(1)
James
H. Ballengee’s address is 5151 Beltline Road, Suite 715 Dallas, Texas 75234. Includes 2,979,456 shares of common stock held
in the name of Jorgan Development, LLC and 30,096 shares of common stock held in the name of JBAH Holdings, LLC. James Ballengee,
in his capacity as sole manager, has sole voting and investment power over both Jorgan Development, LLC and JBAH Holdings, LLC.
(2)
Does
not include options to purchase 917,825 shares of common stock
(3)
The
166,667 shares of common stock beneficially owned by Dr. Hashim are directly held by CSS Nanotech Ltd. Dr. Hashim is the Chief Executive
Officer of CSS Nanotech Ltd.
(4)
The
shares of common stock beneficially owned by Matthew Nicosia includes 4,189,405 shares of common stock held by AKMN Irrevocable Trust
and 262 shares of common stock held by Nicosia Family Trust. Matthew Nicosia is the trustee of the AKMN Irrevocable Trust, of which
Jonathan Nicosia, Matthew Nicosia’s son, a minor, is the beneficiary. Does not include options to purchase 503,935 shares of
common stock.
(5)
Everett
Monroe’s address is 5813 114th Street, Lubbock TX 79424.
(6)
Daniel
O. Ritt Trust’s address is 168 Dover Pkwy, Stewart Manor, NY 11530.
(7)
Peter
D’Arruda’s address is 124 Poppleford Place, Cary, NC 27518.
44
Item 13
- Certain Relationships and Related Transactions and Director Independence
Related
Party Transactions
The
following is a description of each transaction from January 1, 2022 to December 31, 2022, and any material, publicly disclosed
transaction through the date of this filing and each currently proposed transaction in which:
● we
have been or are to be a participant;
● the
amount involved exceeded the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed
fiscal years; and
● any
of our directors, executive officers or holders of more than 5% of our outstanding capital stock, or any immediate family member of,
or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest.
Our
current policy with regard to related party transactions is for the Board as a whole to approve any material transactions involving our
directors, executive officers or holders of more than 5% of our outstanding capital stock.
On
October 28, 2022, we entered into an executive employment agreement with James Ballengee (the “Ballengee Employment Agreement”)
with respect to our appointment of Mr. Ballengee as Chief Executive Officer and Chairman of the Board of Directors. Pursuant to the Ballengee
Employment Agreement, Mr. Ballengee will receive annual compensation of $1,000,000 payable in shares of our common stock, priced at the
volume weighted average price (VWAP) for the five trading days preceding the date of the Ballengee Employment Agreement and each anniversary
thereof (the “CEO Compensation”). The CEO Compensation is subject to satisfaction of Nasdaq rules, the provisions of our
equity incentive plan and other applicable requirements and shall be accrued if such issuance is due prior to satisfaction of such requirements.
Additionally, Mr. Ballengee shall be eligible for a discretionary performance bonus. The Ballengee Employment Agreement may be terminated
by either party for any or no reason, by providing a five days’ notice of termination. As of December 31, 2022, we have accrued
salary owing to Mr. Ballengee of $178,082. Mr. Ballengee’s salary will be paid in shares of our common stock, priced based on the
volume-weighted average price for the preceding five (5) NASDAQ trading days prior to the Effective Date or annual anniversary of his
Employment Agreement, as applicable. The five (5) day volume-weighted average price of our common stock for the salary in 2022 was $1.083.
As a result, we are required to issue Mr. Ballengee 164,434 shares of our common stock as payment for his salary for 2022. At the time
we entered into the Employment Agreement with Mr. Ballengee he was the beneficial holder of approximately 16.66% of our outstanding common
stock.
On
October 24, 2022, the Board of Directors resolved to increase their compensation to (i) $50,000 per year in cash effective August 1,
2022, in equal quarterly payments, with the first such payment, in the amount of $12,500 due November 1, 2022 and, thereafter, $12,500
every February 1, May 1, August 1 and November 1, and (ii) 100,000 stock options priced at $2.50 per share, vesting
immediately. In addition, the Board of Directors approved a one-time payment of $10,000 to each Mr. Trent Staggs and Mr. Al Ferrara for
serving as the Chairperson of the Compensation Committee and Chairperson of the Audit Committee of the Board of Directors, respectively,
payable on November 1, 2022. Al Ferrara resigned from the Audit Committee and Board of Directors on November 28, 2022. Trent
Staggs resigned from the Compensation Committee and the Board of Directors on January 4, 2023. Matthew Balk resigned from the Board
of Directors on January 16, 2023.
In June 2022, we entered into employment
agreements with our former Chief Executive Officer, and our Chief Financial Officer, which provided for annual base salaries of $375,000
and $350,000, respectively, and provided for incremental increases in their salaries upon our achievement of specific performance metrics.
These executives are currently accruing substantial portions of the base salaries. The employment agreements provided for the grant of
stock options to the Chief Executive Officer and Chief Financial Officer to purchase up to 955,093 and 917,825 shares of our common stock,
respectively, at an exercise price equal to 110% and 100% of the fair market value of our common stock on the date of grant. The stock
options vest after two years of continuous employment, subject to acceleration if terminated without cause or resignations for good reason.
The agreements also provided that it was anticipated that the executives receive bonuses for 2022 which would be determined by our Compensation
Committee and Board of Directors after taking into account the general business performance of the company, including any completed financings
and or acquisitions. On September 30, 2022, our Board of Directors received notice from Matthew Nicosia, our former Chief Executive
Officer and Chairman of the Board of Directors of his resignation from such positions. Such resignations are not the result of any disagreement
with us on any matter relating to our operations, policies or practices. Mr. Nicosia vested in 503,935 of these stock options before his
resignation without good reason with the remainder of his stock options were cancelled. As of December 31, 2022, we owed our Chief
Financial Officer. $700,532 in accrued compensation and benefits. As of December 31, 2022, we owed Mr. Nicosia. $402,805 in accrued
compensation and benefits.
45
Viva
Wealth Fund I, LLC (VWFI), which is managed by Wealth Space LLC, has continued its private offering of up to $25,000,000 in convertible
notes for the manufacture of one or more RPC machines. As of December 31, 2022, VWFI has raised $11,750,000. As of December 31,
2022, VWFI has paid $2,266,964 to Dzign Pro Enterprises, LLC (Dzign Pro) for engineering services related to our RPCs, site planning,
and infrastructure, which entity shares a common executive with VWFI. As of December 31, 2022, VWFI also entered into a master revolving
note payable to Dzign Pro in the amount of $300,000, which accrues 5% interest per annum, has a maturity date of July 14, 2024,
where no payments are made prior to the maturity date unless at the option of the fund. VWFI also entered into a master revolving note
payable to Van Tran Family LP, which is an affiliate of WealthSpace, LLC, the VWFI Fund Manager, in the amount of $599,500, which accrues
6% interest per annum, has a maturity date of October 11, 2023, where no payments are made prior to the maturity date unless at
the option of the fund.
On
June 15, 2022, we entered into a Membership Interest Purchase Agreement (the “MIPA”), with Jorgan Development, LLC,
(“Jorgan”) and JBAH Holdings, LLC, (“JBAH” and, together with Jorgan, the “Sellers”), as the equity
holders of Silver Fuels Delhi, LLC (“SFD”) and White Claw Colorado City, LLC (“WCCC”) whereby, at closing, which
occurred on August 1, 2022, we acquired all of the issued and outstanding membership interests in each of SFD and WCCC (the “Membership
Interests”), making SFD and WCCC our wholly-owned subsidiaries. The purchase price for the Membership Interests was approximately
$32.9 million paid for by us with a combination of shares of our common stock, amount equal to 19.99% of the number of issued and outstanding
shares of our common stock immediately prior to issuance, and secured three-year promissory notes issued by us in favor of the Sellers
(the “Notes”). The principal amount of the Notes, together with any and all accrued and unpaid interest thereon, will be
paid to the Sellers on a monthly basis in an amount equal to the Monthly Free Cash Flow beginning on August 20, 2022, and continuing
thereafter on the twentieth (20 th ) calendar day of each calendar month thereafter, as set forth in the MIPA. At the time of
the closing of these transactions Jorgan, JBAH, and our newly hired CEO, James Ballengee were not considered related parties. As James
Ballengee is now our Chief Executive Officer and is the beneficiary of Jorgan and JBAH, and the Sellers now own approximately 16.66%
of our outstanding common shares, certain transactions, as noted below, related to Jorgan, JBAH, and James Ballengee are now considered
related party transactions.
The
consideration for the membership interests included the Notes in the amount of $286,643 to JBAH and $28,377,641 to Jorgan, which accrue
interest of prime plus 3% on the outstanding balance of the notes. Under the MIPA, we have committed to make a payment to Jorgan and
JBAH on or before February 1, 2024 in the amounts of $16,306,754 to Jorgan and $164,715 to JBAH, whether in cash or unrestricted
common stock. In the event of a breach of the terms of the Notes, the sole and exclusive remedy of the holder of the notes will be to
unwind the MIPA transaction. The principal amount of the Notes, together with any and all accrued and unpaid interest thereon, will be
paid to on a monthly basis in an amount equal to the Monthly Free Cash Flow continuing thereafter on the twentieth (20 th )
calendar day of each calendar month thereafter. Monthly Free Cash Flow means cash proceeds received by SFD and WCCC from its operations
minus any capital expenditures (including, but not limited to, maintenance capital expenditures and expenditures for personal protective
equipment, additions to the land/current facilities and pipeline connections) and any payments on the lease obligations of SFD and WCCC.
Subsequent to September 30, 2022, we entered into an agreement amending the Notes, whereby, as soon as is practicable, following
and subject to the approval of our shareholders, and provided there are no applicable prohibitions under the rules of The Nasdaq Capital
Market or other restrictions, we will issue 7,042,254 restricted shares of our common stock as a payment of $10,000,000 toward the principal
of the Notes on a pro rata basis (the “Note Payment”), reflecting a conversion price of $1.42 per share. 6,971,831 shares
will be issued to Jorgan and $9,900,000 of principal owed to Jorgan will be cancelled and 70,423 shares will be issued to JBAH and $100,000
of principal owed to JBAH will be cancelled. Once a registration statement registering the shares for the Note Payment is declared effective
by the SEC, the Note Payment will count against the threshold payment amount, as defined in the notes and the MIPA. As of December 31,
2022 we have accrued interest of approximately $247,914 and made cash payments of $1,565,090.
46
In
the business combination of acquiring WCCC we also acquired WCCC’s Oil Storage Agreement with White Claw Crude, LLC (“WC
Crude”), who shares a beneficiary, James Ballengee, with Jorgan and JBAH. Under this agreement, WC Crude has the right, subject
to the payment of service and maintenance fees, to store volumes of crude oil and other liquid hydrocarbons at a certain crude oil terminal
operated by WCCC. WC Crude is required to pay $150,000 per month even if the storage space is not used. The agreement expires on December 31,
2031. Since acquiring this contract on August 1, 2022 we have received tank storage revenue of approximately $750,000.
In the business combination
of acquiring SFD, we acquired an amended Crude Petroleum Supply Agreement with WC Crude (the “Supply Agreement”), under which
WC Crude supplies volumes of Crude Petroleum to SFD, which provides for the delivery to SFD a minimum of 1,000 sourced barrels per day,
and includes a guarantee that when SFD resells these barrels, if SFD does not make at least a $5.00 per barrel margin on the oil purchased
from WC Crude, then WC Crude will pay to SFD the difference between the sales price and $5.00 per barrel. In the event that SFD makes
more than $5.00 per barrel, SFD will pay WC Crude a profit-sharing payment in the amount equal to 10% of the excess price over $5.00 per
barrel, which amount will be multiplied by the number of barrels associated with the sale. The Supply Agreement expires on December 31,
2031. Since acquiring this contract on August 1, 2022 we have made crude oil purchases from WC Crude of $25,239,962. In addition,
SFD entered into a sales agreement on April 1, 2022 with WC Crude to sell a natural gas liquid product to WC Crude. SFD sells the NGL
stream at cost to WC Crude. We produced and sold natural gas liquids to WC Crude in the amount of $5,890,910 as of December 31, 2022.
In the business combination
of acquiring SFD and WCCC we also entered into a Shared Services Agreement with Endeavor Crude, LLC (“Endeavor”), who shares
a beneficiary, James Ballengee, with Jorgan and JBAH. Under this agreement, we have the right, but not the obligation to use Endeavor
for consulting services. Since entering into this contract on August 1, 2022, we have paid Endeavor $37,993.
In September 2020, we entered into a consulting
contract with LBL Professional Consulting, Inc. (“LBL”), of which our Chief Financial Officer is also an officer, which remains
in effect. For twelve months ended December 31, 2022, LBL invoiced the Company for $340,484. On December 17, 2020 the Company
granted non-statutory stock options to LBL to purchase 333,334 shares of common stock, which was cancelled on September 1, 2022 by
the parties. Our Chief Financial Officer is not the beneficiary of the Company and is not permitted to participate in any discussion,
including LBL’s board meetings, regarding any Company stock that LBL may own at any time.
We
have an existing note payable issued to Triple T, which is owned by Dr. Khalid Bin Jabor Al Thani, the 51% majority-owner of Vivakor
Middle East LLC The note is interest free, has no fixed maturity date and will be repaid from revenues generated by Vivakor Middle East
LLC. As of December 31, 2022 the balance owed was $342,830.
On January 20, 2021, we entered into a worldwide,
exclusive license agreement with TBT Group, Inc. (of which an independent Vivakor Board member at the time was a 7% shareholder of TBT
Group, Inc.) to license piezo electric and energy harvesting technologies for creating self-powered sensors for making smart roadways.
We paid $25,000 and 16,667 shares of restricted common stock upon signing and $225,000 as of April 5, 2022. When the licensor delivers
to us data showing that the sensor performs based on mutually defined specifications and all designs for the sensor are completed, we
shall pay an additional $250,000 and 16,667 shares of restricted common stock. Upon the delivery of a mutually agreed working prototype,
we will pay licensor $250,000 and 16,667 shares of restricted common stock. Upon commercialization of the product, we will pay licensor
$250,000 and 33,333 shares of restricted common stock. TBT shall have the option, at its sole discretion, to convert the license to a
non-exclusive license if we fail to pay $500,000 to TBT for sensor inventory per year, which will commence after the second anniversary
of product commercialization. We shall share in the development costs of the sensor technology to the time of commercialization. From
May 2021 through March 3, 2022, the parties amended the license agreement to extend the terms of the first milestone to March 4,
2022, of which we paid $15,000 as consideration for the extensions and $225,000 to be paid on March 4, 2022.
Policy
on Future Related-Party Transactions
All
future transactions between us and our officers, directors, principal stockholders and their affiliates will be approved by the audit
committee, or a similar committee consisting of entirely independent directors, according to the terms of our Code of Business Conduct
and Ethics and our Related-Party Transaction Policies and Procedures.
47
Item 14
- Principal Accounting Fees and Services
The
aggregate fees billed for the two most recently completed fiscal periods ended December 31, 2022 and December 31, 2021 for
professional services rendered by our independent registered public accounting firm auditors for the audit of our annual consolidated
financial statements, quarterly reviews of our interim consolidated financial statements and services normally provided by independent
accountants in connection with statutory and regulatory filings or engagements for these fiscal periods were as follows:
Year Ended
December 31,
2022
2021
Audit Fees
$ 383,535
$ 172,000
Audit Related Fees
158,108
56,288
Tax Fees
33,149
10,500
Total
$ 574,792
$ 238,788
In
the above table, Audit Fees are fees billed by our company’s external auditor for services provided in auditing our company’s
annual financial statements for the subject year. “Tax fees” are fees billed for professional services rendered for tax compliance,
tax advice and tax planning. The audit fees include review of our interim financial statements and year-end audit.
48
PART
IV
Item 15
- Exhibits and Financial Statement Schedules
The
following documents are filed as part of this Annual Report on Form 10-K:
a)
Financial
Statements:
Our
financial statements and the Report of Independent Registered Public Accounting Firm are included herein on page F-2.
b)
Financial
Statement Schedules:
The
financial statement schedules are omitted as they are either not applicable or the information required is presented in the financial
statements and notes thereto on page F-1.
c)
Exhibits:
49
EXHIBIT
INDEX
Incorporated
by Reference
Filed
or
Furnished
Exhibit No.
Exhibit
Description
Form
Date
Number
Herewith
1.1
Underwriting
Agreement
S-1/A
2/10/22
1.1
2.1
Membership Interest Purchase Agreement dated as of June 15, 2022, by and among the Registrant, Jorgan Development, LLC and JBAH Holdings LLC
8-K
6/22/22
2.1
3.1
Amended
and Restated Articles of Incorporation
S-1
11/10/20
3.1
3.2
Bylaws
S-1
11/10/20
3.2
3.3
Amendments
to Amended and Restated Articles of Incorporation
S-1
11/10/20
3.3
3.4
Form
of Certificate of Change
S-1/A
2/4/22
3.4
4.1
Description of Securities
Filed
4.2
Form
of Representative Warrant
S-1/A
2/10/22
4.1
4.3
Form
of Convertible Promissory Note (2013)
S-1/A
2/12/21
4.2
4.4
Payroll
Protection Program Loan, with Chase Bank
S-1/A
2/12/21
4.4
4.5
Payroll
Protection Program Loan, with Blue Ridge Bank
S-1/A
2/12/21
4.5
4.6
Small
Business Association Loan
S-1/A
2/12/21
4.6
4.7
Form of Secured Promissory Note of Registrant
8-K
6/22/22
4.1
4.8
Form of Note Amendment, dated October 28, 2022
8-K
11/3/22
4.2
10.1
Amended
Contribution Agreement between Sustainable Fuels Incorporated and Vivakor, Inc. dated as of June 15, 2016
S-1
11/10/20
10.1
10.2
Intellectual
Property License Agreement by and between BGreen, LLC and Vivakor, Inc. dated as of September 30, 2020
S-1
11/10/20
10.4
10.3
Patent
and Intellectual Property License Agreement by and between CSS Nanotech, Inc. and Vivakor, Inc. dated as of July 22, 2020
S-1
11/10/20
10.5
10.4*
Employment
Agreement by and between Vivakor, Inc. and Matthew Nicosia
8-K
6/14/22
10.1
10.5*
Employment
Agreement by and between Vivakor, Inc. and Tyler Nelson
8-K
6/14/22
10.2
10.6*
Vivakor,
Inc. 2021 Stock Incentive Plan
S-1/A
2/9/22
10.8
10.7
Intellectual
Property Agreement by and between VivaVentures Precious Metals, LLC and Vivakor, Inc.
S-1/A
4/12/21
10.15
10.8
Form
of Operating Agreement VV UTSI
S-1/A
4/12/21
10.16
10.9
Restated
Working Interest Agreement by and between VivaVentures Energy Group, Inc. and VivaVentures UTSI, LLC
S-1/A
2/12/21
10.17
10.10
Amendment
No. 1 to Amended and Restated Working Interest Agreement by and between VivaVentures Energy Group, Inc. and VivaVentures UTSI, LLC
S-1/A
2/12/21
10.18
10.11
Operating
Agreement VV RII
S-1/A
2/12/21
10.19
10.12
Restated
Working Interest Agreement by and between VivaVentures Energy Group, Inc. and VivaVentures Royalty II
S-1/A
2/12/21
10.20
10.13
Articles
of Association of Vivakor Company
S-1/A
2/12/21
10.21
10.14
Form
of LLC Agreement of IMX
S-1/A
4/12/21
10.22
10.15
Form
of LLC Agreement of RPC Design
S-1/A
4/12/21
10.23
10.16
Form
of LLC Agreement of Viva Wealth
S-1/A
4/12/21
10.24
10.17
Form
of LLC Agreement of VOF
S-1/A
4/12/21
10.25
10.18
Agreement
Regarding Assets, entered into as of December 3, 2018
S-1/A
2/12/21
10.26
10.19
Amendment
to Agreement
S-1/A
2/12/21
10.27
10.20
Amendment
No. 3 to Novus Loan Agreement
S-1/A
4/12/21
10.30
10.21
Amendment No. 4 to Novus Loan Agreement
10-K
4/15/2022
10.21
10.22
Amendment No. 5 to Novus Loan Agreement
10-K
4/15/2022
10.22
10.23
Master
Revolving Note made in favor of Triple T
S-1/A
4/12/21
10.29
10.24
Sensor
Technology License Agreement
S-1/A
7/2/21
10.32
10.25
Amendment
No. 1 to the Sensor Technology License Agreement
S-1/A
7/2/21
10.33
50
10.26
Amendment No. 2 to the Sensor Technology License Agreement
10-K
4/15/22
10.26
10.27
Amendment No. 3 to the Sensor Technology License Agreement
10-K
4/15/22
10.27
10.28
Amendment No. 4 to the Sensor Technology License Agreement
10-K
4/15/22
10.28
10.29
Services
Agreement, entered into on December 14, 2021
8-K
12/20/21
10.1
10.30
Land
Lease Agreement
8-K
3/15/22
10.1
10.31
Product Off-Take Agreement, by and between Vivaventures Energy Group, Inc., and Hot Oil Transport, LLC, dated April 26, 2022
8-K
5/2/22
10.1
10.32*
Executive Employment Agreement, dated June 9, 2022, by and between Vivakor, Inc. and Matthew Nicosia
8-K
6/14/22
10.1
10.33*
Executive Employment Agreement, dated June 9, 2022, by and between Vivakor, Inc. and Tyler Nelson
8-K
6/14/22
10.2
10.34
Form of Shared Services Agreement among Endeavor Crude, LLC, Silver Fuels Delhi LLC and White Claw Colorado City, LLC
8-K
6/22/22
10.1
10.35
Form of Pledge Agreement
8-K
6/22/22
10.2
10.36
Form of Master Netting Agreement among Registrant, Silver Fuels Delhi LLC, White Claw Colorado City, LLC, Jorgan Development, LLC, JBAH Holdings, LLC, Endeavor Crude, LC and White Claw Crude, LLC
8-K
6/22/22
10.3
10.37
Form of Guaranty Agreement
8-K
6/22/22
10.4
10.38
Form of Lock-Up Agreement
8-K
6/22/22
10.5
10.39
Form of Assignment of Membership Agreement
8-K
6/22/22
10.6
10.40
Form of Release Agreement
8-K
6/22/22
10.7
10.41
Oil Storage Agreement dated January 1, 2021 by and between White Claw Colorado City, LLC and White Claw Crude, LLC
8-K
6/22/22
10.8
10.42
Crude Petroleum Supply Agreement dated January 1, 2021 by and between White Claw Crude, LLC and Silver Fuels Delhi LLC
8-K
6/22/22
10.9
Form of first Amendment to Crude Petroleum Supply agreement dated January 1, 2021 by and between White Claw Crude, LLLC and Silver Fuels Delhi LLC
8-K
6/22/22
10.10
10.43*
Executive Employment Agreement, by and between Vivakor, Inc. and James Ballengee, dated October 28, 2022
8-K
11/3/22
10.1
10.44
Land Lease
8-K
12/21/22
10.1
21.1
List of Subsidiaries
Filed
31.1
Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Filed
31.2
Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Filed
32.1
Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Furnished**
32.2
Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Furnished**
101.INS
Inline
XBRL Instance Document
Filed
101.SCH
Inline
XBRL Taxonomy Extension Schema Document
Filed
101.CAL
Inline
XBRL Taxonomy Extension Calculation Linkbase Document
Filed
101.DEF
Inline
XBRL Taxonomy Extension Definition Linkbase Document
Filed
101.LAB
Inline
XBRL Taxonomy Extension Label Linkbase Document
Filed
101.PRE
Inline
XBRL Taxonomy Extension Presentation Linkbase Document
Filed
104
Cover
Page Interactive Data File (formatted in IXBRL, and included in exhibit 101).
*
Management
contract or compensatory plan or arrangement.
**
These
exhibits are being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with
Item 601 of Regulation S-K.
51
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
Vivakor,
Inc.
Date:
May 24, 2023
By:
/s/
James Ballengee
James
Ballengee
Chief
Executive Officer
Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated:
Signature
Title
Date
/s/
James Ballengee
Chief
Executive Officer and Director
May 24,
2023
James
Ballengee
(Principal
Executive Officer)
/s/
Tyler Nelson
Chief
Financial Officer and Director
May
24,
2023
Tyler
Nelson
(Principal
Accounting Officer and
Principal Financial Officer)
/s/
David Natan
Director
May
24,
2023
David
Natan
/s/
John Harris
Director
May
24,
2023
John
Harris
/s/
Albert Johnson
Director
May
24,
2023
Albert
Johnson
52
VIVAKOR,
INC.
INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS
Page
Report of Independent Registered Public Accounting Firm (PCAOB Firm ID 688 )
F-2
Report of Independent Registered Public Accounting Firm (PCAOB Firm ID 324 )
F-3
Audited Consolidated Balance Sheets as of December 31, 2022 and 2021
F-4
Audited Consolidated Statements of Operations for the Years Ended December 31, 2022 and 2021
F-5
Audited Statement of Consolidated Changes in Stockholders’ Equity for the Years Ended December 31, 2022 and 2021
F-6
Audited Statements of Consolidated Cash Flows for the Years Ended December 31, 2022 and 2021
F-7
Notes to the Consolidated Financial Statements
F-8
F- 1
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
Vivakor, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated
balance sheet of Vivakor, Inc. (the “Company”) as of December 31, 2022, the related consolidated statements of operations, changes in
stockholders’ equity and cash flows for the year ended December 31, 2022, and the related notes (collectively referred to as the
“financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial
position of the Company as of December 31, 2022, and the results of its operations and its cash flows for the year ended December 31,
2022, in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the
responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based
on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States)
(“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal
control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
Marcum llp
We have served as the Company’s auditor since 2022.
Houston, Texas
May 24, 2023
F- 2
Report
of Independent Registered Public Accounting Firm
Board
of Directors and Shareholders
Vivakor,
Inc.
Opinion on the Financial Statements
We have audited the accompanying
consolidated balance sheet of Vivakor, Inc. (the Company) as of December 31, 2021, and the related consolidated statements of operations,
stockholders’ equity, and cash flows for the year then ended, and the related notes (collectively referred to as the “consolidated
financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial
position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the year then ended in
conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements
are the responsibility of the entity’s management. Our responsibility is to express an opinion on the entity’s consolidated
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit
in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance
about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to
have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required
to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness
of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing
procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts
and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates
made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit
provides a reasonable basis for our opinion.
Macias
Gini & O’Connell LLP
Irvine,
CA 92618
We have
served as the Company’s auditor since 2021, which ended in 2022
April 15, 2022
F- 3
VIVAKOR, INC.
CONSOLIDATED BALANCE SHEETS
December 31,
2022
2021
ASSETS
Current assets:
Cash and cash equivalents
$ 3,101,186
$ 1,293,767
Cash and cash equivalents attributed to variable interest entity
81,607
199,952
Accounts receivable, less allowances of none and $ 33,000 , respectively
3,563,706
845
Prepaid expenses
31,523
-
Marketable securities
1,652,754
2,231,218
Inventories
47,180
192,000
Precious metal concentrate
-
1,166,709
Other assets
700,298
73,245
Total current assets
9,178,254
5,157,736
Other investments
4,000
4,000
Notes receivable, less allowances of $ 1,162,007 and none
-
1,194,235
Property and equipment, net
22,578,876
24,692,111
Rights of use assets- operating leases
1,880,056
663,291
License agreements, net
1,772,153
2,370,835
Intellectual property, net
28,251,053
13,662,037
Goodwill
12,678,108
-
Total assets
$ 76,342,500
$ 47,744,245
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses
$ 8,688,535
$ 2,023,985
Operating lease liabilities, current
471,991
287,769
Finance lease liabilities, current
963,900
-
Loans and notes payable, current
885,204
1,511,447
Loans and notes payable, current attributed to variable interest entity
1,924,500
3,416,379
Long-term debt (working interest royalty programs), current
9,363
3,256
Total current liabilities
12,943,493
7,242,836
Operating lease liabilities, long term
1,457,483
434,109
Finance lease liabilities, long term
2,298,960
-
Loans and notes payable, long term
28,683,950
1,185,970
Long-term debt (working interest royalty programs)
3,897,553
6,171,298
Deferred income tax liabilities
-
5,156,899
Total liabilities
49,281,439
20,191,112
Stockholders’ equity:
Convertible preferred stock, $ 0.001 par value; 3,400,000 shares authorized; (1)
Series
A- none and 66,667
issued and outstanding, respectively (1)
-
67
Common stock, $ 0.001 par value; 41,666,667 shares authorized; 18,064,838 and 12,330,859 were issued and outstanding as December 31, 2022 and 2021, respectively (1)
18,065
12,331
Additional paid-in capital
74,026,163
58,279,590
Treasury stock, at cost
( 20,000 )
( 20,000 )
Accumulated deficit
( 55,169,781 )
( 35,731,359 )
Total Vivakor, Inc. stockholders’ equity
18,854,447
22,540,629
Noncontrolling interest
8,206,614
5,012,504
Total stockholders’ equity
27,061,061
27,553,133
Total liabilities and stockholders’ equity
$ 76,342,500
$ 47,744,245
(1) Share
and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse
stock split effective February 14, 2022. See Note 1 – Organization and Basis of Presentation
for additional information.
See
accompanying notes to consolidated financial statements
F- 4
VIVAKOR, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
Year Ended
December 31,
2022
2021
Revenues
Product revenue - third parties
$ 21,458,150
$ 1,088,428
Product revenue - related parties
6,649,073
-
Total revenues
28,107,223
1,088,428
Cost of revenues
25,239,962
1,050,676
Gross profit
2,867,261
37,752
Operating expenses:
Sales and marketing
392,914
849,107
General and administrative
9,963,836
4,652,069
Bad debt expense
1,162,007
-
Impairment loss
11,138,830
-
Amortization and depreciation
2,953,629
1,462,492
Total operating expenses
25,611,216
6,963,668
Loss from operations
( 22,743,955 )
( 6,925,916 )
Other income (expense):
Unrealized loss on marketable securities
( 578,464 )
( 1,094,054 )
Interest income
23,725
3,312
Interest expense
( 1,519,281 )
( 501,598 )
Gain on disposition of asset
2,456
87,044
Other income
131,207
125,299
Total other income (expense)
( 1,940,357 )
( 1,379,997 )
Loss before provision for income taxes
( 24,684,312 )
( 8,305,913 )
Benefit for income taxes
4,436,691
1,050,207
Consolidated net loss
( 20,247,621 )
( 7,255,706 )
Less: Net loss attributable to noncontrolling interests
( 809,199 )
( 1,771,535 )
Net loss attributable to Vivakor, Inc.
$ ( 19,438,422 )
$ ( 5,484,171 )
Net loss attributable to common shareholders
$ ( 19,438,422 )
$ ( 5,484,171 )
Dividend on preferred stock
-
42,196
$ ( 19,438,422 )
$ ( 5,526,367 )
Basic and diluted net loss per share (1)
$ ( 1.22 )
$ ( 0.46 )
Basic weighted average common shares outstanding (1)
15,985,103
11,976,116
(1) Share
and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse
stock split effective February 14, 2022. See Note 1 – Organization and Basis of Presentation
for additional information.
See
accompanying notes to consolidated financial statements
F- 5
VIVAKOR,
INC.
CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
Series
A
Preferred Stock
Common
Stock
Additional
Paid-in
Treasury
Accumulated
Non-controlling
Total
Stockholders’
Shares
Amount
Shares
Amount
Capital
Stock
Deficit
Interest
Equity
December
31, 2020 (1)
66,667
$ 67
11,255,967
$ 11,256
$ 45,623,146
$ ( 20,000 )
$ ( 30,204,992 )
1,279,089
$ 16,688,566
Common
Stock issued for services (1)
-
-
33,667
34
437,970
-
-
-
438,004
Common
Stock issued for a reduction of liabilities (1)
-
-
68,611
68
495,731
-
-
-
495,799
Common
Stock issued for the purchase of a license (1)
16,667
17
224,983
-
-
-
225,000
Conversion
of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock (1)
-
-
955,947
956
9,466,648
-
-
-
9,467,604
Stock
options issued for services
-
-
-
-
1,585,000
-
-
-
1,585,000
Stock
based compensation
-
-
-
-
446,112
-
-
-
446,112
Distributions
to noncontrolling interest
-
-
-
-
-
-
-
( 55,050 )
( 55,050 )
Issuance
of noncontrolling interest for a reduction of debt
-
-
-
-
-
-
-
5,560,000
5,560,000
Dividend
paid in Series B-1 Preferred Stock
-
-
-
-
-
-
( 42,196 )
-
( 42,196 )
Net
income (loss)
-
-
-
-
-
-
( 5,484,171 )
( 1,771,535 )
( 7,255,706 )
December
31, 2021 (1)
66,667
$ 67
12,330,859
$ 12,331
$ 58,279,590
$ ( 20,000 )
$ ( 35,731,359 )
$ 5,012,504
$ 27,553,133
Common
Stock issued for stock awards
-
-
16,667
16
( 16 )
-
Common
Stock issued for a reduction of liabilities
-
-
272,156
273
1,144,719
-
-
-
1,144,992
Conversion
of Series A Preferred Stock to Common Stock
( 66,667 )
( 67 )
833,333
833
( 766 )
-
-
-
-
Common
Stock issued for cash
-
-
1,600,000
1,600
6,238,400
-
-
-
6,240,000
Common
stock issued for fractional shares from reverse stock split
-
-
2,271
2
-
-
-
-
2
Common
stock issued as part consideration for the purchase of Silver Fuels Delhi, LLC and White Claw Colorado City, LLC
-
-
3,009,552
3,010
4,284,645
-
-
-
4,287,655
Stock
options issued for services
-
-
-
-
1,472,888
-
-
-
1,472,888
Stock
based compensation
-
-
-
-
2,606,703
-
-
-
2,606,703
Distributions
by noncontrolling interest
-
-
-
-
-
-
-
( 861,691 )
( 861,691 )
Issuance
of noncontrolling interest for a reduction of debt
-
-
-
-
-
-
-
4,865,000
4,865,000
Net
loss
-
-
-
-
-
-
( 19,438,422 )
( 809,199 )
( 20,247,621 )
December
31, 2022
-
$ -
18,064,838
$ 18,065
$ 74,026,163
$ ( 20,000 )
$ ( 55,169,781 )
$ 8,206,614
$ 27,061,061
(1) Share
and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse
stock split effective February 14, 2022. See Note 1 – Organization and Basis of Presentation
for additional information.
See accompanying notes to consolidated
financial statements
F- 6
VIVAKOR, INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS
Year Ended
December 31,
2022
2021
OPERATING ACTIVITIES:
Consolidated net loss
$ ( 20,247,621 )
$ ( 7,255,706 )
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization
2,953,629
1,462,492
Impairment loss
11,138,830
-
Bad debt expense
1,162,007
-
Forgiveness of notes payable
( 130,429 )
( 90,711 )
Common stock options issued for services
1,472,888
1,585,000
Common stock issued for services
-
438,004
Stock-based compensation
2,606,703
446,112
Unrealized loss- marketable
securities
578,464
1,094,054
Gain on disposal of asset
( 2,456 )
( 87,044 )
Deferred income taxes
( 4,437,491 )
( 1,051,007 )
Changes in operating assets and liabilities:
Accounts receivable
2,613,278
6,890
Prepaid expenses
59,900
-
Inventory
162,148
-
Other assets
( 80,220 )
13,807
Right of use assets- finance leases
349,253
Right of use assets- operating leases
( 1,216,765 )
218,513
Operating lease liabilities
1,216,765
( 218,513 )
Financing lease liabilities
( 429,578 )
-
Accounts payable and accrued expenses
( 3,408,157 )
38,128
Interest on notes receivable
( 23,725 )
( 3,313 )
Interest on notes payable
1,519,281
501,598
Net cash used in operating activities
( 4,143,296 )
( 2,901,696 )
INVESTING ACTIVITIES:
Proceeds from notes receivable
55,953
-
Payment on costs of patents
-
( 13,366 )
Acquisition of assets
96,467
-
Purchase of a technology license
-
( 265,000 )
Proceeds from disposal of equipment
6,000
-
Purchase of equipment
( 2,491,175 )
( 4,236,276 )
Net cash used in investing activities
( 2,332,755 )
( 4,514,642 )
FINANCING ACTIVITIES:
Payment of long-term debt
-
( 7,735 )
Proceeds from loans and notes payable
3,640,046
9,135,984
Proceeds from sale of common stock
6,240,000
-
Payment of notes payable
( 853,230 )
( 562,046 )
Distributions to noncontrolling interest
( 861,691 )
( 55,050 )
Net cash provided by financing activities
8,165,125
8,511,153
Net increase (decrease) in cash and cash equivalents
1,689,074
1,094,815
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
1,493,719
398,904
CASH AND CASH EQUIVALENTS, END OF PERIOD
$ 3,182,793
$ 1,493,719
SUPPLEMENTAL CASHFLOW INFORMATION:
Cash paid during the year for:
Interest
$ 1,205,426
$ 390,843
Income taxes
$ -
$ -
Noncash transactions :
Conversion of Series A, B, B-1, and C-1 Preferred Stock to Common Stock
$ 1,200,000
$ 9,467,604
Common stock issued for a reduction in liabilities
$ 1,144,992
$ 495,799
Conversion of note receivable to equity investment
-
81,768
Noncontrolling interest issued for a reduction in liabilities
$ 4,865,000
$ 5,504,950
Preferred stock Series C-1 issued for a reduction in liabilities
$ -
$ 64,950
Common stock issued for the purchase of a license
$ -
$ 225,000
Capitalized interest on construction in process
$ -
$ 1,614,697
Dividend paid in Series B-1 Preferred Stock
$ -
$ 42,196
Common stock and note payable issued
in the acquisition of Silver Fuels Delhi, LLC and White Claw Colorado City, LLC
$ 32,951,939
$ -
Sale of marketable securities for note receivable
-
$ 860,491
Accounts payable on purchase of equipment
259,846
$ 700,000
See accompanying notes to consolidated
financial statements
F- 7
VIVAKOR,
INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Note
1. Organization and Basis of Presentation
Vivakor,
Inc. (collectively “we”, “us,” “our,” “Vivakor” or the “Company”) is a socially
responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as, related environmental
solutions. Currently, our efforts are primarily focused on operating crude oil gathering, storage and transportation facilities, as well
as contaminated soil remediation services. The Company was originally organized on November 1, 2006 as a limited liability company
in the State of Nevada as Genecular Holdings, LLC. The Company’s name was changed to NGI Holdings, LLC on November 3, 2006.
On April 30, 2008, the Company was converted to a C-corporation and changed its name to Vivakor, Inc. pursuant to Articles of Conversion
filed with the Nevada Secretary of State.
On
February 14, 2022, we effected a 1-for-30
reverse split of our outstanding shares of common stock (the “Reverse Stock Split”) via the
filing of a certificate of change with the Nevada Secretary of State which was effective at the commencement of trading of our
Common Stock. No fractional shares of the Company’s common stock were issued as a result of the Reverse Stock Split.
Any fractional shares resulting from the Reverse Stock Split will be rounded up to the nearest whole share. All issued and
outstanding common stock, preferred stock, and per share amounts in the consolidated financial statements and footnotes included
herein have been retroactively adjusted to reflect this reverse stock split for all periods presented.
COVID-19
On
March 11, 2020, the World Health Organization (“WHO”) declared the COVID-19 outbreak to be a global pandemic. In addition
to the devastating effects on human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions
and volatility in the global financial markets. Most U.S. states and many countries have issued policies intended to stop or slow the
further spread of the disease.
COVID-19
and the U.S. response to the pandemic are significantly affecting the economy. There are no comparable events that provide guidance as
to the effect the COVID-19 pandemic may have, and, as a result, the ultimate effect of the pandemic is highly uncertain and subject to
change. We do not yet know the full extent of the effects on the economy, the markets we serve, our business, or our operations. In March 2020
we temporarily suspended operations in Kuwait and Utah due to COVID-19 government restrictions. Utah and Kuwait have since resumed site
preparations for operations. We have experienced supply chain disruptions in building our Remediation Processing Centers (“RPC”)
and completing certain refurbishment on our precious metal extraction machines. These suspensions have had a negative impact on our business
and there can be no guaranty that we will not need to suspend operations again in the future as a result of the pandemic.
Note
2. Liquidity
We
have historically suffered net losses and cumulative negative cash flows from operations, and as of December 31, 2022, we had an
accumulated deficit of approximately $55.2 million. As of December 31, 2022 and 2021, we
had a working capital deficit of approximately $ 3.77
million and $ 2.09
million, respectively. As of December 31,
2022 we had cash of $3.1 million. In addition, we have obligations to
pay approximately $17,500,000 (of which approximately $16,500,000 can be satisfied through the issuance of our common stock under the
terms of the debt and $334,000 is related to PPP loans that are anticipated to be forgiven) of debt in cash within one year of the issuance
of these financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. In
February 2022, the Company closed an underwritten public offering of 1,600,000
shares of common stock, at a public offering
price of $5.00 per share, for aggregate net proceeds of $ 6.2
million, after deducting underwriting discounts,
commissions, and other offering expenses. Prior to the offering, we financed our operations primarily through debt financing, private
equity offerings, and our working interest agreements. We believe the liquid assets from the Company’s available for sale investments
and funding provided from subsequent fundraising activities (see Note 24) of the Company will give it adequate working capital to finance
our day-to-day operations for at least twelve months through May 2024. Our CEO has also committed to provide credit support
through June 2024, as necessary, for an amount up to $8 million to provide the Company sufficient cash resources, if required, to execute
its plans for the next twelve months. Based on the above, we believe these plans alleviate substantial doubt about the Company’s
ability to continue as a going concern.
The Company has prepared the consolidated financial
statements on a going concern basis. If the Company encounters unforeseen circumstances that place constraints on its capital resources,
management will be required to take various measures to conserve liquidity. Management cannot provide any assurance that the Company
will raise additional capital if needed.
F- 8
Note
3. Summary of Significant Accounting Policies
Basis
of Presentation
The
accompanying consolidated financial statements have been prepared in accordance with the Financial Accounting Standards Board (“ FASB ”)
“FASB Accounting Standard Codification™” (the “ Codification ”) which is the source of authoritative
accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of consolidated financial statements
in conformity with generally accepted accounting principles (“ GAAP ”) in the United States.
All
figures are in U.S. dollars unless indicated otherwise.
Principles
of Consolidation
The
consolidated financial statements include the accounts of Vivakor, Inc., its wholly owned and majority-owned active subsidiaries, or
joint ventures (collectively, the “Company”). Intercompany balances and transactions between consolidated entities are eliminated.
Inactive entities have no value, assets or liabilities. Vivakor has the following wholly and majority-owned subsidiaries: Silver Fuels
Delhi, LLC (since August 1, 2022), White Claw Colorado City, LLC (since August 1, 2022), Vivaventures Remediation Corporation,
a Texas corporation, Vivaventures Management Company, Inc., Vivaventures Energy Group, Inc. (99%), Vivaventures Oil Sands, Inc., Vivasphere,
Inc., and Vivakor Middle East, LLC (49%, consolidated). Vivakor manages and consolidates RPC Design and Manufacturing LLC, which includes
a noncontrolling interest investment from Vivaopportunity Fund, LLC, which is also managed by Vivaventures Management Company, Inc. Vivakor
has common officers with and consolidates Viva Wealth Fund I, LLC.
The
Company follows ASC 810-10-15 guidance with respect to accounting for Variable Interest Entities (“VIE”). A VIE is an entity
that does not have sufficient equity at risk to finance its activities without additional subordinated financial support from other parties,
or whose equity investors lack any of the characteristics of a controlling financial interest. A variable interest is an investment or
other interest that will absorb portions of a VIE’s expected losses or receive portions of the entity’s expected residual
returns. Variable interests are contractual, ownership, or other pecuniary interests that change with changes in the fair value of the
entity’s net assets. A party is the primary beneficiary of a VIE and must consolidate it when that party has a variable interest,
or combination of variable interests, that provides the party with a controlling financial interest. A party is deemed to have a controlling
financial interest if it meets both of the power and losses/benefits criteria. The power criterion is the ability to direct the activities
of the VIE that most significantly impact its economic performance. The losses/benefits criterion is the obligation to absorb losses
from, or right to receive benefits from, the VIE that could potentially be significant to the VIE. The VIE model requires an ongoing
reconsideration of whether a reporting entity is the primary beneficiary of a VIE due to changes in facts and circumstances. For the
years ended December 31, 2022 and 2021 the following entities are considered to be a VIE and are consolidated in our consolidated
financial statements: Viva Wealth Fund I, LLC and RPC Design and Manufacturing, LLC. For the years ended December 31, 2022 and 2021
the following entities were considered to be a VIE, but were not consolidated in our consolidated financial statements due to a lack
of the power criterion or the losses/benefits criterion: Vivaventures UTS I, LLC, Vivaventures Royalty II, LLC, Vivaopportunity Fund,
LLC, and International Metals Exchange, LLC. For the years ended December 31, 2022 and 2021 the unaudited financial information
for the unconsolidated VIEs is as follows: Vivaventures UTSI, LLC held assets of $ 1,622,424 and $ 3,753,296 (where the primary asset represents
a receivable from the Company), and liabilities of $ 52,368 and $ 12,608 . Vivaventures Royalty II, LLC held assets of $ 3,670,583 and $ 2,648,810
(where the primary asset represents a receivable from the Company), and liabilities of $ 1,720 and $ 300 . Vivaopportunity Fund LLC held
assets of $ 2,199,781 and $ 2,119,961 (where the primary asset represents a noncontrolling interest in units of a consolidated entity of
the Company) and $ 10,815 and no liabilities. International Metals Exchange, LLC held assets of $ 29,443 and $ 30,461 and liabilities of
$ 1,800 and $ 1,900 .
F- 9
RPC
Design and Manufacturing, LLC: The Company established RPC Design and Manufacturing, LLC (“RDM”) in December 2018
with a business purpose of manufacturing custom machinery and selling or leasing the manufactured equipment in long term contracts with
financing or leasing activities to the Company. We own 100% of the voting rights in RDM. We, as the sole general partner of RDM, have
the full, exclusive and complete right, power and discretion to operate, manage and control the affairs of RDM and take certain actions
necessary to maintain RDM in good standing without the consent of the limited partners. RDM has entered into a license agreement with
the Company indicating that while RDM builds custom machinery incorporating the Company’s hydrocarbon extraction technology, RDM
will pay the Company a license fee of $500,000 per Remediation Processing Center manufactured. RDM has been retained by VWFI to assist
in being the plant manager and will manage and direct the manufacturing of the RPCs. RDM’s license fee is waived for RPC manufacturing
for VWFI. Creditors of RDM have no recourse to the general credit of the Company. For the years ended December 31, 2022 and 2021,
investors in RDM have a noncontrolling interest of $ 227,104 and $ 629,694 , respectively. As of December 31, 2022 and 2021, the cash
and cash equivalents of this VIE are not restricted and can be used to settle the obligations of the reporting entity. As of December 31,
2022 and 2021 this VIE has an outstanding note payable to the reporting entity in the amount of $ 1,288,279 and $ 354,566 , which is eliminated
upon consolidation. We have the primary risk (expense) exposure in financing and operating the assets and are responsible for 100% of
the operation, maintenance and any unfunded capital expenditures, which ultimately could be 100% of a custom machine, and the decisions
related to those expenditures including budgeting, financing and dispatch of power. Based on all these facts, it was determined that
we are the primary beneficiary of RDM. Therefore, RDM has been consolidated by the Company. Any intercompany revenue and expense associated
with RDM and its license agreement with the Company has been eliminated in consolidation.
Viva
Wealth Fund I, LLC: The Company assisted in designing and organizing Viva Wealth Fund I, LLC (“VWFI”) in
November 2020, as a special purpose entity, for the purpose of manufacturing, leasing and selling custom equipment solely to
the Company. Wealth Space, LLC, an unaffiliated entity, is the sole manager. The Company has been retained by the manager, who may
assist in the administrative operations. VWFI has also retained the Company to act as its sole plant manager, and we will manage and
direct all of the manufacturing, leasing and selling of custom equipment in behalf of VWFI to the Company. In November 2020,
VWFI commenced a $25,000,000 private placement offering to sell convertible promissory notes, which convert to VWFI LLC units, to
accredited investors to raise funds to manufacture equipment that will expand the Company’s second RPC, amended to manufacture
one separate double capacity RPC. As of December 31, 2022 and 2021, the cash and cash equivalents of this VIE are restricted
solely for the use of proceeds of the VWFI offering (to manufacture RPCs) and cannot be used to settle the obligations of the
reporting entity. As of December 31, 2022 and 2021, the Company has cash attributed to variable interest entities of $ 81,607
and $ 199,952 .
As of December 31, 2022, VWFI has reached $6,250,000 in funding and has released the funding for construction of RPC Series A.
VWFI has continued fundraising for RPC Series B. In the event that VWFI does not raise at least $8,250,000 for Series B by the
offering termination date (which date was extended until March 31, 2023), then the convertible notes and/or units
would convert into Vivakor common stock where the minimum conversion price will be the greater of $13.50 or a 10% discount to market
per share or in the event of a public offering, 200% of the per share price of the Company common stock sold in the underwritten
offering, which was closed on February 14, 2022 at $5.00 per share. As of March 27, 2023, VWFI has raised approximately
$7,480,000 for RPC Series B. VWFI unit holders may also sell their units to the Company for their principal investment amount on the
3 rd , 4 th , and 5 th anniversary of the offering termination date. The Company also has the option to
purchase any LLC units where the members did not exercise their conversion option under the same terms and pricing for cash or
common stock. VWFI has entered into a license agreement with the Company indicating that VWFI will pay the Company a license fee of
$1,000,000 per series of equipment manufactured with the Company’s proprietary technology. All of the operations of VWFI
relate to private placement offering to fund and manufacture proprietary equipment for the Company, as intended in VWFI’s
design and organization by the Company, so that the Company controls VWFI in its business purpose, use of proceeds, and selling and
leasing of its equipment solely to the Company. Creditors of VWFI have no recourse to the general credit of the Company. We have the
primary risk (expense) exposure in financing and operating the assets and are responsible for 100% of the operation, and any
unfunded capital expenditures, and the expense to the unit holders in conversion to common stock if series of equipment cannot be
fully funded, which ultimately could be 100% of any custom machine. We are responsible for the decisions related to the expenditures
of VWFI proceeds including budgeting, financing and dispatch of power surrounding the series of equipment. Based on all these facts,
it was determined that we are the primary beneficiary of VWFI. Therefore, VWFI has been consolidated by the Company.
F- 10
Business
Combinations
We
apply the provisions of ASC 805, Business Combinations (ASC 805), in accounting for our acquisitions. ASC 805 requires that we evaluate
whether a transaction pertains to an acquisition of assets, or to an acquisition of a business. A business is defined as an integrated
set of assets and activities that is capable of being conducted and managed for the purpose of providing a return to investors. Asset
acquisitions are accounted for by allocating the cost of the acquisition to the individual assets and liabilities assumed on a relative
fair value basis; whereas the acquisition of a business requires us to recognize separately from goodwill the assets acquired and the
liabilities assumed at the acquisition date fair values. Goodwill as of the business acquisition date is measured as the excess of consideration
transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best
estimates and assumptions to accurately value assets acquired and liabilities assumed at the business acquisition date as well as any
contingent consideration, where applicable, our estimates are inherently uncertain and subject to refinement. As a result, during the
measurement period, which may be up to one year from the business acquisition date, we record adjustments to the assets acquired and
liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of a business acquisition’s measurement period
or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are
recorded to our consolidated statements of operations.
In
addition, uncertain tax positions and tax related valuation allowances assumed in a business combination are initially estimated as of
the acquisition date. We reevaluate these items quarterly based upon facts and circumstances that existed as of the business acquisition
date with any adjustments to our preliminary estimates being recorded to goodwill if identified within the measurement period. Subsequent
to the measurement period or our final determination of the tax allowance’s or contingency’s estimated value, whichever comes
first, changes to these uncertain tax positions and tax related valuation allowances will affect our provision for income taxes in our
consolidated statement of operations and could have a material impact on our results of operations and financial position.
Cash
and Cash Equivalents
The
Company considers all highly liquid investments with an original maturity of three months or less when acquired to be cash equivalents.
As of December 31, 2022, the Company had a $750,000 3-month certificate of deposit with B1bank. As of December 31, 2021, the
Company did not have any cash equivalents. The Company places its cash with high credit quality financial institutions. The Company’s
accounts at these institutions are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of December 31,
2022 and 2021, the Company had bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such
financial institutions, the Company annually evaluates the rating of the financial institutions in which it holds deposits. As of December 31,
2022 and 2021, the Company has cash attributed to variable interest entities of $ 81,607 and $ 199,952 . The Company has $ 2,666 in Qatar
National Bank, located in Doha Qatar.
Accounts
Receivable
Accounts
receivable are carried at original invoice amount less an estimated allowance for doubtful accounts, if deemed necessary by management,
and based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts, if any,
by identifying troubled accounts and by using historical experience applied to an aging of accounts. An allowance for doubtful accounts
was considered necessary by management as of December 31, 2021 in the amount of $ 33,000 .
Investments
Investments
in marketable securities consist of equity securities recorded at fair value. Fair value is defined as the price that would be received
to sell an asset in an orderly transaction between market participants at the measurement date. We analyze our marketable securities
in accordance with Accounting Standard Codification 321 (“ASC 321”). Valuations for marketable securities are based on quoted
prices for identical assets in active markets.
The
Company had an investment of $800,000 or 800,000,000 shares of common stock, or a diluted 17% equity holding in Scepter Holdings, Inc.
(ticker: BRZL, OTC Markets) and does not have significant influence, and as the stock is traded on an active market, the Company has
classified the investment as trading securities for the years ended December 31, 2022 and 2021 with the change in unrealized gains
and losses on the investment included in the statement of operations (see Note 7). The Company’s prior Chief Executive Officer,
who resigned as of October 6, 2022, had an immediate family member who sat on the board of directors of Scepter Holdings, Inc.
The Company’s 826,376,882 common shares have a market value of approximately $ 1,322,203 as of April 18, 2023 based on the quoted
market price.
F- 11
As
of December 31, 2022 and 2021, the Company owns 1,000 Class A LLC Units in each of the following entities, which are not consolidated:
Vivaopportunity Fund LLC, Vivaventures UTSI, LLC, Vivaventures Royalty II, LLC, and International Metals Exchange, LLC. In aggregate
these units amount to $ 4,000 as of December 31, 2022 and 2021. These Class A Units give the Company’s management control of
the entities but lack the necessary economics criterion, where the Company lacks the obligation to absorb losses of these entities, as
well as the right to receive benefits from the LLCs.
Convertible
Instruments
The
Company reviews the terms of convertible debt and preferred stock for indications requiring bifurcation, and separate accounting for
the embedded conversion feature. Generally, embedded conversion features where the ability to physical or net-share settle the conversion
option is not within the control of the Company or the number of shares is variable are bifurcated and accounted for as derivative financial
instruments. (See Derivative Financial Instruments below). Bifurcation of the embedded derivative instrument requires the allocation
of the proceeds first to the fair value of the embedded derivative instrument with the residual allocated to the host instrument. The
resulting discount to the debt instrument or the redemption value of convertible preferred securities is accreted through periodic charges
to interest expense over the term of the agreements or to dividends over the period to the earliest conversion date using the effective
interest rate method, respectively.
Derivative
Financial Instruments
The
Company does not use derivative financial instruments to hedge exposures to cash-flow or market risks. However, certain other financial
instruments, such as warrants to purchase the Company’s common stock and the embedded conversion features of debt and preferred
instruments that are not considered indexed to the Company’s common stock are classified as liabilities when either (a) the holder
possesses rights to net-cash settlement, (b) physical or net share settlement is not within the control of the Company, or (c) based
on its anti-dilutive provisions. In such instances, net-cash settlement is assumed for financial accounting and reporting. Such financial
instruments are initially recorded at fair value and subsequently adjusted to fair value at the close of each reporting period. Fair
value for embedded conversion features and option-based derivative financial instruments is determined using the Monte Carlo Simulation
or the Black-Scholes Option Pricing Model, respectively.
Other
convertible instruments that are not derivative financial instruments are accounted for by recording the intrinsic value of the embedded
conversion feature as a discount from the initial value of the instrument and accreting it back to face value over the period to the
earliest conversion date using the effective interest rate method.
Leases
The
Company follows Accounting Standards Codification 842, Leases (“ASC 842”). We determine if an arrangement contains
a lease at inception based on whether or not the Company has the right to control the asset during the contract period and other facts
and circumstances.
We
are the lessee in a lease contract when we obtain the right to control the asset. Lease right-of-use (“ROU”) assets represent
our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising
from the lease, both of which are recognized based on the present value of the future minimum lease payments over the lease term at the
commencement date. Leases with a lease term of 12 months or less at inception are not recorded on our consolidated balance sheet and
are expensed on a straight-line basis over the lease term in our consolidated statement of operations. We determine the lease term by
assuming the exercise of renewal options that are reasonably certain. As most of our leases do not provide an implicit interest rate,
we use our local incremental borrowing rate based on the information available at the commencement date in determining the present value
of future payments. According to ASC 842, the Company has measured the lease liabilities acquired on August 1, 2022 by measuring the present value of the remaining lease payments, as if the lease were acquired on acquisition date. The right-of-use assets were measured at the same amount as the lease liabilities as adjusted to reflect favorable or unfavorable terms of the lease when compared with market terms. Finance ROU assets are included in property, plant, equipment, net (see Note 11). As of December 31, 2022 and
2021, we recorded operating right-of-use assets of $ 1,880,056 and $ 663,291 , operating lease obligations of $ 1,929,474 and $ 721,878 , and
finance lease obligations of $ 3,262,860 and none .
F- 12
Long
Lived Assets
The
Company reviews the carrying values of its long-lived assets for possible impairment whenever events or changes in circumstances indicate
that the carrying amount may not be recoverable. If the expected future cash flow from the use of the asset and its eventual disposition
is less than the carrying amount of the asset, an impairment loss is recognized and measured using the fair value of the related asset.
On
March 11, 2020, the World Health Organization (“WHO”) declared the COVID-19 outbreak to be a global pandemic. In addition
to the devastating effects on human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions
and volatility in the global financial markets. Most U.S. states and many countries have issued policies intended to stop or slow the
further spread of the disease. The Company’s Kuwait operations were suspended to comply with the social distancing measures implemented
in Kuwait, but in 2022 has allowed for the Company to obtain site personnel visas to recommence operations for site refurbishments. The
Company’s Utah operations were temporarily suspended from March through May 2020, but have since resumed in full in its manufacturing
of its RPCs, and infrastructure preparations. Currently the operations at the Company’s Vernal plant are limited due to recent,
supply and personnel limitations. The Company is not currently producing product toward our off-take agreement due to these
recent developments. The Company continues to assess the impact of these limitations, including the impact on our ancillary agreements.
Ancillary to our Vernal, Utah operations, the Company have an exclusive license agreement with TBT Group, Inc., under which we are exploring
the possibilities of embedding self-powered sensors directly into the asphaltic cement we may generate from the Vernal, Utah RPC utilizing
TBT Group’s piezo electric and energy harvesting technologies. For the year ended December 31, 2022 we realized an impairment
loss of $447,124 on this license agreement with TBT Group due to the current disruptions at the Vernal, Utah facility.
As of December 31, 2022 we continued to
pursue a test facility or third party reactor for our nano catalyst technology that facilitates chemical manufacturing, with a focus
on the production of ammonia . The Company received recent quotes for testing or building
our own test facilities with new partners for this venture with estimates of cost being over $4 million. The Company does not anticipate
pursing this cost of testing at this time. After taking into consideration this new information, we noted that the newly requested capital
expenditure to test and scale the business triggered an impairment loss of assets related to our ammonia synthesis assets of $3,254,999.
We have previously extracted and sold precious metals using our extraction
machinery and held extracted precious metals from those operations of the machinery for monetization. The operations surrounding our precious
metals extraction services were temporarily suspended until recently, although due to these suspended activities and a shift in 2022 of
the Company’s focus to the oil and gas industry, we have realized an impairment loss of $1,166,709 surrounding our precious metal
concentrate and an impairment loss of $6,269,998 surrounding the extraction machinery.
No
impairment charges were incurred during the year ended December 31, 2021.
There
can be no assurance that market conditions will not change or demand for the Company’s services will continue, which could result
in impairment of long-lived assets in the future.
Property
and equipment, net
Property
and equipment are stated at cost or fair value when acquired. Depreciation is computed by the straight-line method and is charged to
the statement of operations over the estimated useful lives of the assets. Leasehold improvements are depreciated over the shorter of
the estimated useful lives of the assets or the term of the related lease. Impairment losses are recognized for long-lived assets, including
definite-lived intangibles, used in operations when indicators of impairment are present and the undiscounted cash flows estimated to
be generated by those assets are not sufficient to recover the assets’ carrying amount. Impairment losses are measured by comparing
the fair value of the assets to their carrying amount.
Interest
on long-term debt for the development or manufacturing of Company assets is capitalized to the asset until the asset enters production
or use, and thereafter all interest is charged to expense as incurred. Maintenance and repairs are charged to expense as incurred. Leasehold
improvements are depreciated over the shorter of the estimated useful lives of the assets or the term of the related lease.
F- 13
The
carrying amount and accumulated depreciation of assets sold or retired are removed from the accounts in the year of disposal and any
resulting gain or loss is included in results of operations. The estimated useful lives of property and equipment are as follows:
Schedule of useful lives for property plant and equipment
Computers, software, and office equipment
1 - 5 years
Machinery and equipment
3 - 5 years
Vehicles
5 years
Furniture and fixtures
5 - 10 years
crude oil gathering, storage, and transportation facilities
10 years
Remediation Processing Centers (heavy extraction and remediation equipment) (“RPC”)
20 years
Leasehold improvements
Lesser of the lease term or estimated useful life
Equipment
that is currently being manufactured is considered construction in process and is not depreciated until the equipment is placed into
service.
Intangible
Assets and Goodwill:
We
account for intangible assets and goodwill in accordance with ASC 350 “Intangibles-Goodwill and Other” (“ASC
350”). Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible
assets acquired. Intangible asset amounts represent the acquisition date fair values of identifiable intangible assets acquired. The
fair values of the intangible assets were determined by using the income approach, discounting projected future cash flows based on management’s
expectations of the current and future operating environment. The rates used to discount projected future cash flows reflected a weighted
average cost of capital based on our industry, capital structure and risk premiums including those reflected in the current market capitalization.
Definite-lived intangible assets are amortized over their useful lives, which have historically ranged from 10 to 20 years. The carrying
amounts of our definite-lived intangible assets are evaluated for recoverability whenever events or changes in circumstances indicate
that the entity may be unable to recover the asset’s carrying amount.
We
assess our intangible assets in accordance with ASC 360 “ Property, Plant, and Equipment ” (“ASC 360”).
Impairment testing is required when events occur that indicate an asset group may not be recoverable (“triggering events”).
As detailed in ASC 360-10-35-21, the following are examples of such events or changes in circumstances (sometimes referred to as impairment
indicators or triggers): (a) A significant decrease in the market price of a long-lived asset (asset group) (b) A significant adverse
change in the extent or manner in which a long-lived asset (asset group) is being used or in its physical condition. (c) A significant
adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset group), including
an adverse action or assessment by a regulator (d) An accumulation of costs significantly in excess of the amount originally expected
for the acquisition or construction of a long-lived asset (asset group) (e) A current-period operating or cash flow loss combined with
a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of
a long-lived asset (asset group) (f) A current expectation that, more likely than not, a long-lived asset (asset group) will be sold
or otherwise disposed of significantly before the end of its previously estimated useful life. The term more likely than not refers to
a level of likelihood that is more than 50 percent. We have evaluated our intangible assets and found that certain losses and a delay
in our business plan may have constituted a triggering event for our intangible assets. We performed an analysis and assessed an impairment
loss in the following areas: Currently the operations at the Company’s Vernal plant are limited due to recent, temporary supply
and personnel limitations. The Company is not currently producing product toward our off-take agreement due to these recent developments.
Ancillary to our Vernal, Utah operations, the Company has an exclusive license agreement with TBT Group, Inc., under which we are exploring
the possibilities of embedding self-powered sensors directly into the asphaltic cement we may generate from the Vernal, Utah RPC utilizing
TBT Group’s piezo electric and energy harvesting technologies. For the year ended December 31, 2022 we realized an impairment
loss of $ 447,124 on this license agreement with TBT Group due to the current disruptions at the Vernal, Utah facility. As of December 31,
2022 we continued to pursue a test facility or third party reactor for our nano catalyst technology that facilitates chemical manufacturing,
with a focus on the production of ammonia . The Company received recent quotes for testing
or building our own test facilities with new partners for this venture. After taking into consideration this new information, we noted
that the newly requested capital expenditure to test and scale the business triggered an impairment loss of assets related to our ammonia
synthesis assets (including it’s patents) of $3,254,999.
F- 14
The
Company performs its annual goodwill impairment test in the fourth quarter each year, and more frequently if facts and circumstances
indicate such assets may be impaired, including significant declines in actual or future projected cash flows and significant deterioration
of market conditions.
The
Company’s goodwill impairment assessment includes a qualitative assessment to determine whether it is more likely than not that
the fair value of the goodwill is below its carrying value, each year, and more often if there are significant changes in business conditions
that could result in impairment. When a quantitative analysis is considered necessary for the annual impairment analysis of goodwill,
the Company develops an estimated fair value for the reporting unit considering three different approaches: 1) market value, using the
Company’s stock price plus outstanding debt; 2) discounted cash flow analysis; and 3) multiple of earnings before interest, taxes,
depreciation and amortization based upon relevant industry data.
The
estimated fair value of the reporting unit is then compared to its carrying amount, including goodwill. If the estimated fair value exceeds
the carrying amount, goodwill is not considered impaired. If the carrying amount, including goodwill, exceeds its estimated fair value,
any excess of the carrying value of goodwill of the reporting unit over its fair value is recorded as an impairment. No goodwill impairment
loss was incurred during the year ended December 31, 2022.
Asset
Retirement Obligations
Under
ASC 410-20, Asset Retirement and Environmental Obligations – Asset Retirement Obligations, which relates to accounting requirements
for costs associated with legal obligations to retire tangible, long-lived assets, the Company records an Asset Retirement Obligation
(“ARO”) at fair value in the period in which it is incurred by increasing the carrying amount of the related long-lived asset.
In each subsequent period, liability is accreted over time towards the ultimate obligation amount and the capitalized costs are depreciated
over the useful life of the related asset. The Company did not identify any significant or material cost after review; thus, no ARO obligation
is recorded for the year ended December 31, 2022.
Share-Based
Compensation
Share-based
compensation is accounted for based on the requirements of ASC 718, “Compensation-Stock Compensation’ (“ASC 718”)
which requires recognition in the financial statements of the cost of employee, consultant, or director services received in exchange
for an award of equity instruments over the period the employee, consultant, or director is required to perform the services in exchange
for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee, consultant, or director
services received in exchange for an award based on the grant-date fair value of the award.
Income
tax
Deferred
income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary
differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences.
Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income
tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all
of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes
in tax laws and rates on the date of enactment.
Our
annual effective tax rate is based on our income and the tax laws in the various jurisdictions in which we operate. Judgment is required
in determining our annual tax expense and in evaluating our tax positions. We establish reserves to remove some or all of the tax benefit
of any of our tax positions at the time we determine that the position becomes uncertain based upon one of the following conditions:
(1) the tax position is not “more likely than not” to be sustained; (2) the tax position is “more likely than not”
to be sustained, but for a lesser amount; or (3) the tax position is “more likely than not” to be sustained, but not in the
financial period in which the tax position was originally taken. For purposes of evaluating whether or not a tax position is uncertain,
(1) we presume the tax position will be examined by the relevant taxing authority that has full knowledge of all relevant information;
(2) the technical merits of a tax position are derived from authorities such as legislation and statutes, legislative intent, regulations,
rulings and case law and their applicability to the facts and circumstances of the tax position; and (3) each tax position is evaluated
without considerations of the possibility of offset or aggregation with other tax positions taken. We adjust these reserves, including
any impact on the related interest and penalties, in light of changing facts and circumstances, such as the progress of a tax audit.
See Note 22 for further information on income tax.
F- 15
Revenue
Recognition
We
follow Accounting Standards Codification 606, Revenue from Contracts with Customers (“ASC 606”).
The revenue standard contains a five-step approach
that entities will apply to determine the measurement of revenue and timing of when it is recognized, including (i) identifying the contract(s)
with a customer, (ii) identifying the separate performance obligations in the contract, (iii) determining the transaction price, (iv)
allocating the transaction price to separate performance obligations, and (v) recognizing revenue when (or as) each performance obligation
is satisfied. The standard requires a number of disclosures intended to enable users of financial statements to understand the nature,
amount, timing and uncertainty of revenue, and the related cash flows. The disclosures include qualitative and quantitative information
about contracts with customers, significant judgments made in applying the revenue guidance, and assets recognized from the costs to obtain
or fulfill a contract.
Due to the business combination
in which we acquired Silver Fuels Delhi, LLC and White Claw Colorado City, LLC, for the year ended December 31, 2022, our sales
consist of storage services and the sale of crude oil or like products. For the year ended December 31, 2022, disaggregated revenue by customer type was as follows: $ 21,409,300 in crude oil sales and $ 5,890,910 in product related to natural gas liquids sales.
We recognize revenue when we transfer promised goods or services
to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services.
After completion of our performance obligation, we have an unconditional right to consideration as outlined in our contracts. Due to
the nature of our product we do not accept returns. Our receivables will generally be collected in less than three months, in accordance
with the underlying payment terms.
For
the year ended December 31, 2021, approximately 99% of our sales consisted of the sale of precious metals with a commitment to deliver
precious metals to the customer, and revenue is recognized on the settlement date, which is defined as the date on which: (1) the quantity,
price, and specific items being purchased have been established, (2) metals have been shipped to the customer, and (3) payment has been
received or is covered by the customer’s established credit limit with the Company.
In
order to ensure the revenue recognition in the proper period, we review material sales contracts for proper cut-off based upon the business
practices and legal requirements of each country.
Related Party Revenues
We sell sale of crude oil or like products and provide storage services
to related parties under long-term contracts. We acquired these contracts in our August 1, 2022 acquisition of Silver Fuels Delhi, LLC
and White Claw Colorado City, LLC. These contracts were entered into in the normal course of our business. Our revenue from related parties
for 2022 was $ 6,649,073 .
Major
Customers and Concentration of Credit Risk
The
Company has two major customers, which account for approximately 100 % of the balance of accounts receivable as of December 31, 2022
and 99 % of the Company’s revenues for the year ended December 31, 2022. Additionally, the Company operates in the crude oil
industry. The industry concentration has the potential to impact the Company’s overall exposure to credit risk in that its customer
may be similarly affected by changes in economic, industry or other conditions. There is risk that the Company would not be able to identify
and access replacement markets at comparable margins.
Contingent
liabilities
From
time to time the Company may work with success based professional service providers, including securities counsel for private offerings,
which may require contingent payments to be made based on the future offering fundraising and financial performance of the offering.
In the event that an offering does not perform or is never consummated, the Company may still be required to pay a portion of the success
fees for the services provided in preparing the offering. The fair value of the contingent payments would be estimated using the present
value of management’s projections of the financial results. Failure to correctly project the financial results of the offering
or settlement of legal fees related to the offering could materially impact our results of operations and financial position.
Advertising
Expense
Advertising
costs are expensed as incurred. The Company did not incur advertising expense for the years ended December 31, 2022 and 2021.
F- 16
Recent
Accounting Pronouncements
Under
the Jumpstart Our Business Startups Act, or the JOBS Act, we meet the definition of an “emerging growth company.” We have
irrevocably elected to opt-out of the extended transition period for complying with new or revised accounting standards pursuant to Section 107(b)
of the JOBS Act. As a result, we comply with new or revised accounting standards on the relevant dates on which adoption of such
standards is required for non- emerging growth companies.
In
December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2019-12, Simplifying the Accounting for Income Taxes , which eliminates certain exceptions related to the approach for intraperiod
tax allocation, the methodology for calculating taxes during the quarters and the recognition of deferred tax liabilities for outside
basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and changes in tax laws or rates, as well
as clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 became effective for
the Company beginning January 1, 2021.
In
August 2020, the Financial Accounting Standards
Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06 Debt—Debt with Conversion and Other
Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for
Convertible Instruments and Contracts in an Entity’s Own Equity, which improves Convertible
Instruments and Contracts in an Entity’s Own Equity and is expected to improve financial reporting associated with accounting for
convertible instruments and contracts in an entity’s own equity. The ASU simplifies accounting for convertible instruments by removing
major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single
liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion
features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception,
which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted earnings per share (EPS) calculation in
certain areas.
In
May 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2021-04
Earnings Per Share (Topic 260), Debt— Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation
(Topic 718), and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40), provides a “principles-based
framework to determine whether an issuer should recognize the modification or exchange as an adjustment to equity or an expense.” These amendments are effective for fiscal years beginning after December 15, 2021. The Company has adopted this pronouncement and it has not materially impacted our consolidated financial statements.
The
FASB issued ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, in October 2021.
The guidance improves the accounting for acquired revenue contracts with customers in a business combination by requiring contract assets
and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in
accordance with ASC Topic 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. This guidance
will be effective for fiscal years beginning after December 15, 2022, including interim periods within that year, with early adoption
permitted. The Company has early adopted this pronouncement and it has not materially impacted our consolidated financial statements.
Net
Income/Loss Per Share
Basic
net income (loss) per share is calculated by subtracting any preferred interest distributions from net income (loss), all divided by
the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted
net income (loss) per common share is computed by dividing the net income (loss) by the weighted-average number of common share equivalents
outstanding for the period determined using the treasury stock method if their effect is dilutive. Potential dilutive instruments as
of December 31, 2022 and 2021 include the following: convertible notes payable convertible into approximately 14,560 and 192,834
shares of common stock, stock options granted to employees of 1,421,760 and 183,333 shares of common stock, stock options granted to
Board members or consultants of 395,139 and 466,667 shares of common stock. The Company also has a warrant outstanding to purchase 80,000
shares of common stock as of December 31, 2022.
F- 17
Use
of Estimates
The
preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires
management to make estimates, judgments, and assumptions that affect the amounts reported in the consolidated financial statements and
accompanying notes. We believe our critical accounting estimates relate to the following: Recoverability of current and noncurrent assets,
revenue recognition, stock-based compensation, income taxes, effective interest rates related to long-term debt, marketable securities,
cost basis investments, lease assets and liabilities, valuation of stock used to acquire
assets, derivatives, and fair values of the intangible assets and goodwill related to business combinations.
While
our estimates and assumptions are based on our knowledge of current events and actions we may undertake in the future, actual results
may ultimately differ from these estimates and assumptions.
Fair
Value of Financial Instruments
The
Company follows Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures” (“ASC
820”), for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair
value to be applied to existing generally accepted accounting principles that requires the use of fair value measurements, establishes
a framework for measuring fair value, and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have
an impact on the Company’s financial position or operating results but did expand certain disclosures.
ASC
820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the
use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:
Level
1: Applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
Level
2: Applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability
such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets
with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are
observable or can be derived principally from, or corroborated by, observable market data.
Level
3: Applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the
measurement of the fair value of the assets or liabilities.
The
Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s
(“FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in
their entirety based on the lowest level of input that is significant to the fair value measurement. The carrying amounts reported in
the consolidated balance sheets for marketable securities are classified as Level 1 assets due to observable quoted prices for identical
assets in active markets. The carrying amounts reported in the consolidated balance sheets for cash, prepaid expenses and other current
assets, accounts payable and accrued expenses approximate their estimated fair market values based on the short-term maturity of these
instruments. The recorded values of notes payable approximate their current fair values because of their nature, rates, and respective
maturity dates or durations.
Note
4. Business Combination
On
June 15, 2022, we entered into a Membership Interest Purchase Agreement (the “MIPA”), with Jorgan Development, LLC
(“Jorgan”) and JBAH Holdings, LLC (“JBAH” and, together with Jorgan, the “Sellers”), as the
equity holders of Silver Fuels Delhi, LLC (“SFD”) and White Claw Colorado City, LLC (“WCCC”) whereby, at
closing, which occurred on August 1, 2022, the Company acquired 100% of the issued and outstanding membership interests in each
of SFD and WCCC (the “Membership Interests”), making SFD and WCCC wholly owned subsidiaries of the Company. The purchase
price for the Membership Interests was approximately $32.9 million, after post-closing adjustments, paid for by the Company with
a combination of shares of the issuance of 3,009,552 of
the Company’s common stock and secured three-year promissory notes made by the Company in favor of the Sellers in an aggregate
amount of $ 28,664,284 .
F- 18
For
the acquisition of Silver Fuels Delhi, LLC and White Claw Colorado City, LLC, the following table summarizes the acquisition date fair
value of consideration paid, identifiable assets acquired and liabilities assumed:
Schedule of recognized identified assets acquired and liabilities assumed
Common stock
$ 4,287,655
Note payable to seller
28,664,284
Fair value of total consideration paid
$ 32,951,939
Net assets acquired and liabilities assumed
Assets acquired in business combination
Current assets
$ 6,573,359
Finance lease right-of-use assets (property, plant and equipment)
3,579,544
Property, plant and equipment, net
705,110
Other assets
546,834
Contract-based intangible assets
19,095,420
Total assets acquired
$ 30,500,265
Liabilities assumed in business combination
Current liabilities
$ ( 7,489,639 )
Long term liabilities
( 2,736,795 )
Total liabilities acquired
$ ( 10,226,434 )
Total net assets acquired
$ 20,273,831
Goodwill
$ 12,678,108
The
value of goodwill represents SFD and WCCC’s ability to generate profitable operations going forward. Management engaged a valuation expert who performed a valuation
study to calculate the fair value of the acquired assets and goodwill. The acquired contracts are amortized over their 9 year,
5 month life of the contracts.
Business
combination related costs were expensed as incurred and consisted of various advisory, legal, accounting, valuation and other professional
fees of $174,592 for the year ended December 31, 2022. These costs are included in general and administrative expense in our
consolidated statement of operations.
Since
the date of acquisition on August 1, 2022 through December 31, 2022 $ 28,058,374 of sales in aggregate is attributed to SFD
and WCCC. The unaudited financial information in the table below summarizes the combined results of operations of the Company, SFD, and
WCCC for the years ended December 31, 2022 and 2021, on a pro forma basis, as though the companies had been combined as of January 1,
2021. The pro forma earnings for the years ended December 31, 2022 and 2021, were adjusted to include intangible amortization expense
of contracts acquired of $ 2,027,832 , respectively. The pro forma earnings for the years ended December 31, 2022 and 2021, were adjusted
to include interest expense on notes payable that were issued as consideration of $ 1,152,842 and $ 1,773,603 , respectively. The $ 174,592
of acquisition-related expenses were excluded from the year ended December 31, 2022, and included in the year ended December 31,
2021, as if the acquisition occurred at January 1, 2021. The unaudited pro forma financial information does not purport to be indicative
of the Company’s combined results of operations which would actually have been obtained had the acquisition taken place on January 1,
2021, nor should it be taken as indicative of future consolidated results of operations.
Schedule of proforma information
(Unaudited)
Years ended
December 31,
2022
2021
Total net sales
$ 64,009,714
$ 34,361,233
Loss from operations
21,659,746
7,429,978
Net loss (attributable to Vivakor, Inc.)
$ 23,944,546
$ 8,085,238
Basic and diluted loss per share
( 1.35 )
( 0.54 )
Weighted average shares outstanding
17,733,117
14,985,668
F- 19
Note
5. Accounts receivable
Accounts
receivable primarily relates to sales to trade accounts receivable of customers for crude oil. Differences between the amounts due from
customers less an estimated allowance for doubtful accounts, if deemed necessary by management, and based on a review of all outstanding
amounts on a monthly basis. Management determines the allowance for doubtful accounts, if any, by identifying troubled accounts and by
using historical experience applied to an aging of accounts. As of December 31, 2022 and 2021 an allowance for doubtful accounts
of none and $ 33,000 was deemed necessary. Trade accounts receivable are zero interest bearing. Trade accounts receivable of $ 948,352
are with a vendor of which our CEO is a beneficiary.
Note
6. Prepaid Expenses and Other Assets
As
of December 31, 2022 and 2021, we other assets of $ 700,298 and $ 73,245 . Our other assets consist of various deposits with vendors, professional service agents, or security
deposits on office and warehouse leases, including operating lease deposits in the amount of $ 132,688 and $ 47,388 as of December 31, 2022 and 2021, a deposit for a reclamation bond with the Utah Division of Oil, Gas and Mining in the amount
of $ 14,288 as of December 31, 2022 and 2021, and finance lease deposits of $ 553,322 as of December 31, 2022, which will be returned at the end of the finance
leases after we have complied with the terms of the lease (see Note 17).
As of December 31, 2022, our prepaid expenses
of $ 31,523 mainly consists of prepaid insurances.
Note
7. Marketable Securities
Investments
in marketable securities consist of equity securities recorded at fair value. Fair value is defined as the price that would be received
to sell an asset in an orderly transaction between market participants at the measurement date. We analyze our marketable securities
in accordance with Accounting Standard Codification 321 (“ASC 321”). Valuations for marketable securities are based on quoted
prices for identical assets in active markets. Where marketable securities were found not be part of an actively traded market, we made
a measurement alternative election and estimate the fair value at cost of the investment minus impairment.
In
December 2021 we sold 3,309,758 shares of common stock of Odyssey Group International, Inc. (“Odyssey”) ticker: ODYY,
OTC Markets in a private transaction for a purchase price of $ 860,491 , with $10,000 cash delivered at signing and a note issued in favor
of Vivakor in the amount of $850,491 (see Note 10), reflecting the market price at that time. The Company recorded an unrealized gain
of $ 203,540 on these marketable securities for the year ended December 31, 2021.
The
Company owns 826,376,882 shares of common stock of Scepter Holdings, Inc. (“Scepter”), ticker: BRZL, OTC Markets., for a
diluted 17% equity holding in the company. In August 2021 we converted $ 81,768 of our note receivable with Scepter into 26,376,882
shares of Scepter common stock pursuant to the terms of the note at $0.0031 per share. On the date of the conversion, the Scepter price
per share on OTC Markets was $0.0062 per share, which resulted in a $ 87,044 gain on the disposition of the note receivable. The Company
accounted for such securities based on the quoted price from the OTC Markets where the stock is traded which resulted in the Company
recording an unrealized loss on marketable securities of $ 578,464 and $ 1,297,594 for the years ended December 31, 2022 and 2021.
The Company’s previous Chief Executive Officer, who resigned on October 6, 2022, had an immediate family member who sits on
the board of directors of Scepter Holdings, Inc. As of December 31, 2022 and 2021 our marketable securities were valued at $ 1,652,754
and $ 2,231,218 .
As
of December 31, 2022 and 2021, marketable securities were $ 1,652,754 and
$ 2,231,218 .
For the years ended December 31, 2022 and 2021, the Company recorded a total net unrealized loss of $ 578,464
and $ 1,094,054
on marketable securities in the statement of operations.
F- 20
Note
8. Inventories
As
of December 31, 2022, inventories consist of crude oil. The crude oil is related to our oil gathering facility in Delhi, Louisiana. As of December 31, 2022 an impairment loss of $ 192,000 related to the Fenix Iron was realized.
As of December 31, 2021 inventories consist primarily of the Fenix Iron. The nano Fenix Iron are finished goods that have a 20-year
shelf life and were acquired at cost for $ 192,000 . Inventories are valued at the lower of cost or market (net realizable value).
Note
9. Precious Metal Concentrate
Precious
metal concentrate includes metal concentrates located at the Company’s facilities. Concentrates consist of gold, silver, platinum,
palladium, and rhodium. Precious metal concentrate was acquired from our funding agreements for extraction operations with Vivaventures
Precious Metals LLC from 2013 through 2016. Our precious metal concentrate requires further refining to be sold as a finished product
and is valued at the lower of cost or market (net realizable value).
As
of December 31, 2021, the Company carried a refining reserve of $ 1,166,709
against its precious metal concentrate asset based on estimates that the Company received if it were to sell the precious metal
concentrate in its current concentrated form to processing refineries. The Company intends to sell our precious metal concentrate in
its current state or refine it into dore bars for sale or monetization and investment purposes. As of December 31, 2021 the net
realizable value of our precious metal concentrate was $ 1,166,709 .
The operations surrounding our precious metals were temporarily suspended until recently. Due to these suspended activities, and a shift in 2022 of the Company’s focus to the oil and gas industry, we have
not been able to sell our precious metals in their concentrate form as anticipated, and have reserved the remaining $ 1,166,709
surrounding our precious metal concentrate for the year ended December 31, 2022.
Note
10. Notes Receivable
Notes receivable are carried at the receivable
amount less an estimated reserve for troubled accounts. Management determines the reserve for troubled accounts by analyzing notes receivable
for non-performance, including the payment history of the notes receivable.
Notes receivable consist of the following:
Schedule Of notes receivable
December 31,
2022
2021
PLC International Investments,
Inc. (a)
-
860,491
TMC Capital,
LLC (b)
-
333,744
Total Notes Receivable
$ -
$ 1,194,235
(a)
In December 2021
we sold such 3,309,578 shares of Odyssey common stock in a private transaction for a purchase price of $860,491, reflecting the market
price as of such time. Such purchase price was paid in the form of $10,000 cash delivered at signing and a note issued in favor of
Vivakor in the amount of $850,491 accruing interest at 3% per annum, with payments due quarterly over a five year term. As of December 31,
2022 we have reserved against the note in the amount of $828,263.
(b)
The Company
has a $333,744 note receivable with TMC Capital, LLC, an affiliate of MCW Energy Group Limited. The parties amended the agreement
in December 2021 to have the note paid on or before October 1, 2022. As of December 31, 2022 we have reserved against
the note in the amount of $333,744.
F- 21
Note
11. Property and Equipment
The
following table sets forth the components of the Company’s property and equipment at December 31, 2022 and 2021:
Schedule of property and equipment, net
December
31, 2022
December
31, 2021
Gross
Carrying Amount
Accumulated
Depreciation/Amortization
Net
Book Value
Gross
Carrying Amount
Accumulated
Depreciation
Net
Book Value
Office
furniture
$ 14,998
$ 5,912
$ 9,086
$ 14,998
$ 4,000
$ 10,998
Vehicles
36,432
26,110
10,322
48,248
26,306
21,942
Equipment
763,852
277,288
486,564
-
-
-
Property
140,000
-
140,000
-
-
-
Finance
lease- Right of use assets
3,579,544
349,253
3,230,291
-
-
-
Precious
metal extraction machine- 1 ton
-
-
-
2,280,000
228,000
2,052,000
Precious
metal extraction machine- 10 ton
-
-
-
5,320,000
532,000
4,788,000
Construction
in process:
Bioreactors
-
-
-
1,440,000
-
1,440,000
Wash
Plant Facilities
199,800
-
199,800
Nanosponge/Cavitation
device
44,603
-
44,603
22,103
-
22,103
Remediation
Processing Unit 1
4,396,753
-
4,396,753
6,249,082
-
6,249,082
Remediation
Processing Unit 2
6,285,547
-
6,285,547
5,201,098
-
5,201,098
Remediation
Processing Unit System A
3,893,051
-
3,893,051
2,561,467
-
2,561,467
Remediation
Processing Unit System B
3,845,398
-
3,845,398
2,345,421
-
2,345,421
Total
fixed assets
$ 23,256,006
$ 677,130
$ 22,578,876
$ 25,482,417
$ 790,306
$ 24,692,111
For
the year ended December 31, 2021 the Company paid $ 64,950 with 5,413 shares of Series C-1 Preferred Stock for equipment, which has
been valued based on similar cash purchases of the Series C-1 Preferred Stock at approximately $12.00 per share. For the years ended
December 31, 2022 and 2021 depreciation expense was $ 638,073 and $ 11,561 . For the years ended December 31, 2022 and 2021 capitalized
interest to equipment from debt financing was none and $ 1,614,697 . Equipment that is currently being manufactured is considered construction
in process and is not depreciated until the equipment is placed into service. Equipment that is temporarily not in service is not depreciated
until placed into service.
The operations surrounding our precious metals
extraction services were temporarily suspended until recently, although due to these suspended activities and a shift in 2022 of the Company’s
focus to the oil and gas industry, we have realized an impairment loss of $6,269,998 surrounding the extraction machinery for the year
ended December 31, 2022.
As of December 31, 2022 we continued to pursue
a test facility or third party reactor for our nano catalyst technology that facilitates chemical manufacturing, with a focus on the
production of ammonia, which includes our bioreactor equipment . The Company received recent
quotes for testing or building our own test facilities with new partners for this venture. After taking into consideration this new information,
we noted that the newly requested capital expenditure to test and scale the business triggered an impairment loss of assets related to
our ammonia synthesis assets, including our bioreactors. The impairment loss related to our bioreactors was $1,440,000 for the year ended
December 31, 2022.
F- 22
Note
12. License Agreements
On
August 17, 2017, the Company purchased rights to an exclusive license for the applications and implementations involving the Nanosponge
Technology and to use and develop the Nanosponge as we see fit at our sole discretion. The Nanosponge contribution in the Company’s
processes is to facilitate a cracking process whereby remediated or extracted oil may be further refined from a crude product to a diesel
fuel. The license was valued at $ 2,416,572 and is amortized over its useful life of 20 years. As of December 31, 2022 and 2021 the
accumulated amortization of the license was $ 644,419 and $ 523,591 . For the years ended December 31, 2022 and 2021 amortization expense
of the license was $ 120,829 . Amortization expense for the years 2023 through 2027 is $ 120,829 in each respective year. As of December 31,
2022 and 2021 the net value of the license is $ 1,772,153 and $ 1,892,981 , respectively.
On
January 20, 2021, the Company entered into a worldwide, exclusive license agreement with TBT Group, Inc. (of which an
independent Vivakor Board member is a 7% shareholder) to license piezo electric and energy harvesting technologies for creating
self-powered sensors for making smart roadways. The Company paid $25,000 and 16,667 shares of restricted common stock upon signing.
On March 4, 2022, the Company paid licensor an additional $225,000. When the licensor delivers to the Company data
showing that the sensor performs based on mutually defined specifications and all designs for the sensor are completed, Company
shall pay an additional $250,000 and 16,667 shares of restricted common stock. Upon the delivery of a mutually agreed working
prototype, Company will pay licensor $250,000 and 16,667 shares of restricted common stock. Upon commercialization of the product,
the Company will pay licensor $250,000 and 33,333 shares of restricted common stock. TBT shall have the option, at its sole
discretion, to convert the license to a non-exclusive license if the Company fails to pay $500,000 to TBT for sensor inventory per
year, which will commence after the second anniversary of product commercialization. The Company shall share in the development
costs of the sensor technology to the time of commercialization.
The Company amended the agreement multiple times in 2021 to extend the terms of the first milestone payment of $ 225,000 payment
to the licensor, and further amended the agreement in March 2022 to finally extend the payment to be no later than
March 4, 2022. The Company paid consideration of $15,000 for these amended extensions. Currently the operations at our Vernal
plant are limited due to recent, temporary supply and personnel limitations. We are not currently producing product toward the
off-take agreement due to these recent developments. Ancillary to our Vernal, Utah operations, is our exclusive license agreement
with TBT Group, Inc., For the year ended December 31, 2022 we realized an impairment loss of $ 447,124 on
this license agreement due to the current disruptions at the Vernal, Utah facility. The Company is in the process of analyzing data
received for this product.
F- 23
Note
13. Intellectual Property, Net and Goodwill
The
following table sets forth the components of the Company’s intellectual property at December 31, 2022 and 2021:
Schedule Of Intellectual Property
December 31, 2022
December 31, 2021
Gross
Carrying
Amount
Accumulated
Amortization
Net Book
Value
Gross
Carrying
Amount
Accumulated
Amortization
Net Book
Value
Extraction Technology patents
$ 113,430
$ 12,233
$ 101,197
$ 113,430
$ 5,560
$ 107,870
Extraction Technology
16,385,157
6,485,791
9,899,366
16,385,157
5,666,534
10,718,623
Acquired crude oil contracts
19,095,420
844,930
18,250,490
-
-
-
Ammonia synthesis patents
-
-
-
4,931,380
2,095,836
2,835,544
Total Intellectual property
$ 35,594,007
$ 7,342,954
$ 28,251,053
$ 21,429,967
$ 7,767,930
$ 13,662,037
The
changes in the carrying amount of goodwill are as follows:
Schedule of goodwill
Goodwill
January 1, 2021
$ -
Acquisition
12,678,108
December 31, 2022
$ 12,678,108
There is no goodwill
as of December 31, 2021.
On
August 1, 2022, the Company closed a Membership Interest Purchase Agreement, (the “MIPA”), with Jorgan Development,
LLC, and JBAH Holdings, LLC, as the equity holders of Silver Fuels Delhi, LLC, a Louisiana limited liability company (“SFD”)
and White Claw Colorado City, LLC, a Texas limited liability company (“WCCC”) whereby, the Company acquired all of the issued
and outstanding membership interests in each of SFD and WCCC making SFD and WCCC wholly owned subsidiaries of the Company. The purchase
price for the Membership Interests is approximately $ 32.9 million, after post-closing adjustments.
In
the business combination of acquiring WCCC we also acquired WCCC’s Oil Storage Agreement with White Claw Crude, LLC (“WC
Crude”), of which our CEO is a beneficiary. Under this agreement, WC Crude has the right, subject to the payment of service and
maintenance fees, to store volumes of crude oil and other liquid hydrocarbons at a certain crude oil terminal operated by WCCC. WC Crude
is required to pay $150,000 per month even if the storage space is not used. The agreement expires on December 31, 2031.
In the business combination
of acquiring SFD, we acquired an amended Crude Petroleum Supply Agreement with WC Crude (the “Supply Agreement”), under which
WC Crude supplies volumes of Crude Petroleum to SFD, which provides for the delivery to SFD a minimum of 1,000 sourced barrels per day,
and includes a guarantee that when SFD resells these barrels, if SFD does not make at least a $5.00 per barrel margin on the oil purchased
from WC Crude, then WC Crude will pay to SFD the difference between the sales price and $5.00 per barrel. In the event that SFD makes
more than $5.00 per barrel, SFD will pay WC Crude a profit-sharing payment in the amount equal to 10% of the excess price over $5.00 per
barrel, which amount will be multiplied by the number of barrels associated with the sale. The Supply Agreement expires on December 31,
2031.
F- 24
Management
hired a valuation expert who performed a valuation study to calculate the fair value of the acquired assets, assumed liabilities and goodwill. Based on the valuation
study, the fair values of goodwill and the acquired contracts (described above) were $ 12,678,108 and $ 19,095,420 on August 1, 2022.
The acquired contracts are amortized over a 9 year, 5 month life. The amortization expense of the acquired contracts was $ 844,930 from
the date of acquisition on August 1, 2022 through December 31, 2022, and amortization expense for the years 2023 through 2027
is $ 2,027,832 in each respective year. As of December 31, 2022 the net carrying value of the acquired contracts is $ 18,250,490 .
The
Company entered into a Contribution Agreement dated January 5, 2015, where proprietary information and intellectual property related
to certain petroleum extraction technology (also known as hydrocarbon extraction technology) suitable to extract petroleum (or hydrocarbons)
from tar sands and other sand-based ore bodies, and all related concepts and conceptualizations thereof (the “Extraction Technology”)
was contributed to VivaVentures Energy Group, Inc., a 99% majority-owned subsidiary of Vivakor, and was assessed a fair market value
of $ 16,385,157 , which consists of the consideration of $11,800,000 and the Company assuming a deferred tax liability in the amount of
$4,585,157. All ownership in the Extraction Technology (including all future enhancements, improvements, modifications, supplements,
or additions to the Extraction Technology) was assigned to the Company and is currently being applied to the Company Remediation Processing
Centers, which are the units that remediate material. The Extraction Technology is amortized over a 20 -year life. For
the years ended December 31, 2022 and 2021 the amortization expense of the technology was $ 819,258 . Amortization expense
for the years 2023 through 2027 is $ 819,258 in each respective year. As of December 31, 2022 and 2021 the net carrying value of the Extraction
Technology is $ 9,899,366 and $ 10,718,623 .
In
2019, the Company began the process of patenting the Extraction Technology and all of its developments and additions since the acquisition,
and we have filed a series of patents and capitalized the costs of these patents. As of December 31, 2022 and 2021, the capitalized
costs of these patents are $ 113,430 . The patents were placed in service in 2021 and are amortized over the patents’ useful life
of twenty years. For the year ended December 31, 2022 and 2021 the amortization expense of
the patents was $ 6,672 and $ 5,560 . Amortization expense for the years 2023 through 2027 is $ 5,672 in each respective year. As
of December 31, 2022 and 2021 the net carrying value of the patents is $ 101,197 and $ 107,870 .
The
Company entered into an asset purchase agreement dated September 5, 2017, where two patents (US patent number 7282167- Method
and apparatus for forming nano-particles and US patent number 9272920- System and
method for ammonia synthesis ) were purchased and attributed a fair market value of $ 4,931,380 ,
which consists of the consideration of $3,887,982 and the Company assuming a deferred tax liability in the amount of $1,043,398. The
patents grant the Company ownership of a nano catalyst technology that facilitates chemical manufacturing, with a focus on the
production of ammonia, specifically for the gas phase condensation process used to create the
iron catalyst. As of December 31, 2022 we continued to pursue a test facility or third party reactor for our nano
catalyst technology . The Company received recent quotes for testing or building our own
test facilities with new partners for this venture with estimates of cost being over $4 million. After taking into consideration
this new information, we noted that the newly requested capital expenditure to test and scale the business triggered a net
impairment loss to fully impair the patents, and the deferred tax liability related to the patents was reduced, yielding a net
impairment loss of $1,622,998.
The
patents were being amortized over their useful life of 10 years before the impairment was triggered. For the years ended December 31,
2022 and 2021 the amortization expense of the patents was $ 493,138 . As of December 31, 2022 and 2021 the net carrying value of the patents
was none and $ 2,835,544 .
F- 25
Note
14. Accounts Payable and Accrued Expenses
Accounts
payable and accrued expenses consist of the following:
Schedule of accounts payable and accrued expenses
December 31,
2022
2021
Accounts payable
$ 5,022,302
$ 1,450,531
Office access deposits
235
340
Accrued compensation
1,302,890
175,000
Unearned revenue
20,936
-
Accrued interest (various notes and loans payable
380,175
-
Accrued interest (working interest royalty programs)
1,437,711
-
Accrued tax penalties and interest
524,286
398,114
Accounts payable and accrued expenses
$ 8,688,535
$ 2,023,985
As
of December 31, 2022, our accounts payable are primarily made up of trade
payable for the purchase of for crude oil . Trade accounts payables in the amount of $ 4,000,681
is with a vendor who our CEO is a beneficiary of. $37,685 of accounts payable related to services rendered, which are not trade payables,
are with a vendor who our CEO is a beneficiary of. $43,934 of accounts payable related to services rendered, which are not trade payables,
are with a vendor where our Chief Financial Officer sits on the board of the directors and is an officer.
As
of December 31, 2021 the Company accrued $ 225,000 for a milestone payment to be paid to TBT
Group, Inc. (of which an independent Vivakor Board member is a 7% shareholder) related to our worldwide, exclusive license agreement
for the license of piezo electric and energy harvesting technologies for creating self-powered sensors for making smart roadways. This
milestone payment was paid in March 2022.
In March 2023, the Compensation Committee reviewed the Company’s
2022 results, including, but not limited to, the progress of the Company’s historic business and certain acquisitions completed
by the Company, and approved discretionary bonuses, which have been accrued as of December 31, 2022, for the Chief Financial Officer,
and an acquisition consultant, in the amounts of $ 505,467 (included in accrued compensation) and $ 421,222 (included in accounts payable),
respectively.
Note
15. Stock Payable
In
2019, the Company had an outstanding payable of $ 11,800,000
payable in common stock to Sustainable Fuels, Inc. (“SFI”) for the Extraction Technology (See Note 13). Before the
Common Stock was issued, the owner of SFI died and the matters and affairs of his estate were passed to the executor of his estate.
We attempted to contact SFI and the executor of the estate multiple times to issue and send the common stock to the company or
appropriate successor of the estate to no avail. In 2021, the Company was able to make contact with the new owner of SFI and we issued 20,000,000
shares of Common Stock to SFI per the terms of the agreement.
F- 26
Note
16. Loans and Notes Payable
Loans
and notes payable and their maturities consist of the following:
Schedule of loans and notes payable
December 31,
2022
2021
Various promissory notes
and convertible notes (a)
$ 50,960
$ 50,960
Novus Capital Group LLC Note (b)
171,554
378,854
Triple T Notes (c)
342,830
353,330
National Buick GMC (d)
16,006
19,440
Various Convertible Bridge Notes (e)
-
1,075,813
Blue Ridge Bank (f)
410,200
410,200
Small Business Administration (g)
299,900
318,175
JP Morgan Chase Bank (h)
-
90,645
Jorgan Development, LLC (i)
27,977,704
-
Various variable
interest promissory notes (j)
2,224,500
3,416,379
Total Notes Payable
$ 31,493,654
$ 6,113,796
Loans and notes payable, current
$ 885,204
$ 1,511,447
Loans and notes payable, current attributed to variable interest entity
1,924,500
3,416,379
Loans and notes payable, long term
$ 28,683,950
$ 1,185,970
Schedule of maturities of loans and notes payable
2023
$ 2,809,704
2024
16,843,748
2025
11,577,052
2026
33,640
2027
17,232
Thereafter
212,278
Total
$ 31,493,654
(a)
From 2013 through 2018
the Company issued a series of promissory notes and convertible notes with various interest rates ranging up to 12% per annum. The
convertible notes convert at the holder’s option after 1 year of issuance and may be converted into shares of common stock.
The conversion price is generally equal to the specified per share conversion rate as noted in the note agreements.
(b)
In 2017, the Company acquired
assets, including patents, in the amount of $4,931,380 in which the Company also agreed to assume the encumbering debt on asset in
the amount of $334,775. The debt currently accrues interest at 10% per annum. In November 2021, the lender agreed to extend
the maturity of the note to April 1, 2022. On April 1, 2022, the lender agreed to extend the maturity of the note to April 1,
2023 with an initial payment of $52,448 and approximate monthly payment of $29,432 thereafter until the note is fully paid.
(c)
The balance of this note
is due to a related party, a company owned by the 51% owner of Vivakor Middle East LLC. The loan was granted to Vivakor Middle East
LLC by the majority owner for operational use. On March 10, 2021, the Company entered into a master revolving note with Triple
T Trading Company LLC to set forth the relationship of the parties to retain the previous terms of the note payable to Triple T Trading
Company LLC, to include a note maturity of March 10, 2023, and maximum lending amount of 1,481,482 QAR or approximately $400,000,
valued at an exchange rate of approximately $0.27 per QAR on December 31, 2022. Subsequent to December 31, 2022 the parties
agreed to extend the maturity date of the loan to March 10, 2024.
F- 27
(d)
In May 2019, the Company
purchased a vehicle for $36,432 and financed $34,932 over six years with an interest rate of 6.24% per annum. Monthly payments of
$485 are required and commenced in July 2019.
(e)
In 2020 the Company entered
into various convertible promissory notes as follows:
Throughout
2021 and 2020 the Company entered into convertible promissory notes with an aggregate principal of $ 415,000 . The notes accrue interest
at 10 % per annum and have a maturity of the earlier of 12 months or the consummation of the Company listing its Common Stock on a senior
stock exchange. The notes are convertible at the Company’s option into shares of the Company’s common stock at a price equal
to 80% of the opening price of the Company’s common stock on the national exchange or the offering price paid by the investors
in the financing in connection with the uplist, whichever is lower, or (ii) repaid in cash in an amount equal to the indebtedness being
repaid plus a premium payment equal to 15% of the amount being repaid. If an event of default has occurred and the Company does not convert
the amounts due under the Note into the Company’s common stock, then the Company will have the option to convert the outstanding
indebtedness into shares of the Company’s common stock at a price equal to 80% of the weighted average trading price of the Company’s
common stock, or be repaid in cash in an amount equal to all principal and interest due under the Note. All of these
notes were converted to common stock as of April 5, 2022.
On
October 13, 2020, the Company entered into a convertible promissory note in an amount of $280,500 having an interest rate of 12%
per annum. The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00
or 80% of the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the
note may be converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in conjunction
with this note, which was recorded as a debt discount
in the amount of $44,000, which is amortized to interest expense over the term of the agreements using the effective interest method.
On March 28, 2021 the parties amended this agreement to state that in no event shall the conversion price be lower than $3.00 per
share. In October 2021 the parties agreed to extend the maturity of this loan to April 13, 2022 in exchange for an increase
in principal owed of $30,000. This note was converted to common stock as of April 13, 2022.
On
February 4, 2021, the Company entered into a convertible promissory note in an amount of $277,778 having an interest rate of 12%
per annum. The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00
or 80% of the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the
note may be converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in conjunction
with this note, which was recorded as a debt discount
in the amount of $36,000, which is amortized to interest expense over the term of the agreements using the effective interest method.
On March 28, 2021 the parties amended this agreement to state that in no event shall the conversion price be lower than $3.00 per
share. In February 2022 the parties agreed to extend the maturity of this loan to August 8, 2022 in exchange for an increase
in principal owed of $25,000. This note was converted to common stock as of April 13, 2022.
(f)
In
May 2020, the Company entered into a Paycheck Protection Program (“PPP”) loan agreement for $205,100 with Blue Ridge
Bank, subject to the Small Business Administration’s (“SBA”) Paycheck Protection Program. The loan carries an annual
interest rate of one (1) percent per annum with payment beginning in the seventh month with monthly payments required until maturity
in the 18 th month. The loan may be fully forgivable according to the CARES Act if the Company can provide proper documentation
for the use of the proceeds of the loan. The Company has achieved the milestones for loan forgiveness and anticipates that this debt
will be forgiven in full in 2021. On January 6, 2021 the Company was granted an extension of the PPP and granted an additional
$205,100 from Blue Ridge Bank, subject to the Small Business Administration’s (“SBA”) Paycheck Protection Program.
The loan carries an annual interest rate of one (1) percent per annum with payment beginning in the tenth month with monthly payments
required until maturity in five years. The loan may be fully forgivable according to the CARES Act if the Company can provide proper
documentation for the use of the proceeds of the loan. The Company has achieved the milestones for loan forgiveness, has applied
for loan forgiveness, and anticipates that this debt will be forgiven in full.
F- 28
(g)
From
May through August 2020, the Company entered into two loan agreements with the Small Business Administration for an aggregate
loan amount of $299,900. The loans carry an interest rate of 3.75% per annum. The loans shall mature in 30 years.
(h)
In
April 2021, the Company entered into a Paycheck Protection Program loan agreement with JP Morgan Chase Bank, subject to the
Small Business Administration’s (“SBA”) Paycheck Protection Program. The loan may be fully forgivable according
to the CARES Act if the Company can provide proper documentation for the use of the proceeds of the loan. The Company received loan
forgiveness of this debt in 2022.
(i)
On August 1, 2022,
we closed a Membership Interest Purchase Agreement, (the “MIPA”), with Jorgan Development, LLC, (“Jorgan”)
and JBAH Holdings, LLC (“JBAH”), as the equity holders of Silver Fuels Delhi, LLC (“SFD”) and White Claw
Colorado City, LLC (“WCCC”) whereby, the Company acquired all of the issued and outstanding membership interests in each
of SFD and WCCC, making SFD and WCCC wholly owned subsidiaries of the Company. The consideration for the membership interests included
secured three-year promissory notes in the amount of $286,643 to JBAH and $28,377,641 to Jorgan, which accrue interest of prime plus
3% on the outstanding balance of the notes. Under the MIPA, the Company has committed to make a payment to Jorgan and JBAH on or
before February 1, 2024 in the amounts of $16,306,754 to Jorgan and $164,715 to JBAH, whether in cash or unrestricted common
stock. In the event of a breach of the terms of the notes, the sole and exclusive remedy of the holder of the notes will be to unwind
the MIPA transaction. The principal amount of the notes, together with any and all accrued and unpaid interest thereon, will be paid
on a monthly basis in an amount equal to the Monthly Free Cash Flow continuing thereafter on the twentieth (20 th ) calendar
day of each calendar month thereafter. Monthly Free Cash Flow means cash proceeds received by SFD and WCCC from its operations minus
any capital expenditures (including, but not limited to, maintenance capital expenditures and expenditures for personal protective
equipment, additions to the land/current facilities and pipeline connections) and any payments on the lease obligations of SFD and
WCCC. In October 2022, we entered into an agreement amending the notes issued as consideration in the MIPA, whereby, as soon
as is practicable, following and subject to the approval of the Company’s shareholders, and provided there are no applicable
prohibitions under the rules of The Nasdaq Capital Market or other restrictions, the Company will issue 7,042,254 restricted shares
of the Company’s common stock as a payment of $10,000,000 toward the principal of the note on a pro rata basis, reflecting
a conversion price of $1.42 per share. Once the registration statement is declared effective by the SEC, the Note Payment will count
against the threshold payment amount, as defined in the notes and the MIPA. For the year ended December 31, 2022, the Company
paid $399,932 in principal and $872,404 in interest to Jorgan. For the year ended December 31, 2022, the Company paid $286,643
in principal and $6,111 in interest to JBAH paying this note off in full.
(j)
The balance
of these various promissory notes are related to the special purchase vehicle, Viva Wealth Fund I, LLC (VWFI) of which the balance
primarily related to an offering up to $25,000,000 in convertible notes in a private offering. As of December 31, 2022, VWFI
has raised $11,750,000 and converted $10,425,000 of this debt to VWFI LLC units. A convertible note will automatically convert into
the LLC units at the earlier of (i) the date that the Equipment is placed into quality control and testing or (ii) six months from
the date of investment. The convertible notes will accrue interest at 12% per annum and are paid quarterly. At the maturity date,
remaining interest will be paid, at which time no further interest payments will accrue. Upon the offering termination date, all
units accepted for any series of equipment will automatically convert to Vivakor common stock if the Company has not accepted subscriptions
for at least $8,250,000 for Series B of the equipment. The conversion price of the automatic stock conversion will be the greater
of $13.50 or a 10% discount to market per share or in the event of a public offering, 200% of the per share price of the Company
common stock sold in an underwritten offering, which was closed on February 14, 2022 at $5.00 per share. The termination date
of the offering has been extended until March 31, 2023 in the sole discretion of VWFI. As of April 28, 2021 VWFI has reached
$6,250,000 in funding and has released the funding for construction of RPC Series A. VWFI has commenced fundraising for RPC Series
B, and as of December 31, 2022, VWFI has raised approximately $5,500,000 to manufacture RPC Series B. Subsequent to December 31,
2022 an additional $1,980,000 has been raised in relation this offering, and $555,000 of this debt has been converted into units
of the LLC. VWFI has also entered into various master revolving notes outside of the offering: $599,500, from a related party of
VWFI, which accrues 6% interest per annum, has a maturity date of October 11, 2023, where no payments are made prior to the
maturity date unless at the option of the fund; $300,000, from a related party of VWFI, which accrues 5% interest per annum, has
a maturity date of July 14, 2024, where no payments are made prior to the maturity date unless at the option of the fund.
F- 29
Note
17. Commitments and Contingencies
Finance
Leases
In
the business combination where we acquired Silver Fuels Delhi, LLC (SFD) and White Claw Colorado City, LLC (WCCC), we acquired certain
finance leases contracts and liabilities as described below:
On
March 17, 2020, the SFD entered into two sale and leaseback transactions with Maxus Capital Group, LLC (“Maxus”).
The first transaction involved the Company assigning twelve storage tanks and other equipment for consideration of $ 1,025,000
and subsequently entering into an agreement to lease the assets back from Maxus for 60 monthly payments of $ 22,100 .
At the end of the lease term there is an option purchase the assets back from Maxus at a purchase price of $ 1 .
The second transaction involved the Company assigning the remaining property at the oil gathering facility with the exception of land, to Maxus for consideration of $ 1,350,861
and subsequently entering into an agreement to lease the assets back from Maxus for 60 monthly payments of $ 18,912 .
At the end of the lease term, there is an option to purchase the assets back from Maxus at a purchase price of $ 877,519 .
The land, contains the oil gathering facility, is being used as collateral by the lessor
for both lease obligations.
We
are required to make minimum cash reserve payments of at least $ 24,000 ($ 8,945 and $ 15,055 for the first and second lease, respectively)
each month in addition to the base lease payments. The cash reserve payments are to be used in the event of a default. At the end of
the term, Maxus will return the balance of any cash reserve payments. As of December 31, 2022, the balances of the cash reserves
for these leases were $ 369,109 (see Note 6). As these leases grant the lessee an option to purchase the underlying asset that the lessee is reasonably
certain to be exercised, the leases are accounted for as finance leases. We have recorded right of use assets in our property, plant,
and equipment, and depreciated them on a straight-line basis. We have also recorded a finance lease liability due to Maxus. According to ASC 842, the Company has measured the lease liability and at the present value of the remaining lease payments, as if the lease were acquired on acquisition date of August 1, 2022. This measurement as
imputed interest rate of 18 % for the first and second lease obligations, which results in the carrying value of the financial
liabilities equating the estimated book value of the leased assets at the end of the lease terms and the dates at which the Company may
exercise its buy-back options. Future minimum lease payments for each of the next three years under the Maxus lease obligations is as
follows: 2023 $ 492,144 , 2024 $ 492,144 , and 2025 $ 123,036 .
On
December 28, 2021, the WCCC entered into a sale and leaseback transaction with Maxus, where WCCC assigned the crude oil, natural
gas liquids, condensate, and liquid hydrocarbon receipt, throughput, processing, gathering, and delivery terminal, commonly known as
the China Grove Station (the “China Grove Station”), located in Colorado City, Texas to Maxus for consideration of approximately $ 2,500,000
and entered into a lease agreement to lease the China Grove Station back from Maxus for 60 monthly payments of $ 39,313 . At the end of
the lease term, the Company has an option to purchase the China Grove Station back from Maxus at 35% of the original cost, or $ 875,000 .
The Company has pledged 100% of its interests in accounts receivable as collateral for the lease obligation. The Company is required
to make minimum cash reserve payments of at least $ 16,100 each month in addition to the base lease payments until Maxus has received
$ 471,756 . The cash reserve payments are to be used in the event of default. As of December 31, 2022, the balance of the cash reserves
for these leases were $ 144,900 . As these leases grant the lessee an option to purchase the underlying asset that the lessee is reasonably
certain to be exercised, the leases are accounted for as finance leases. We have recorded right of use assets in our property, plant,
and equipment, and depreciated them on a straight-line basis. We have also recorded a finance lease liability due to Maxus. According to ASC 842, the Company has measured the lease liability and at the present value of the remaining lease payments, as if the lease were acquired on acquisition date of August 1, 2022. This measurement as yielded an imputed interest rate of 18 % for the lease obligation, which results in the carrying value of the financial liability equating
the estimated book value of the China Grove Station at the end of the lease term and the date at which the Company may exercise its buy-back
option. Future minimum lease payments for each of the next four years under the Maxus lease obligation are as follows:
2023 $ 471,756 , 2024 $ 471,756 , 2025 $ 471,756 , and 2026 $ 471,756 .
F- 30
The
following table reconciles the undiscounted cash flows for the finance leases as of December 31, 2022 to the finance lease liability
recorded on the balance sheet:
Schedule of financing lease liability
2023
$ 963,900
2024
963,900
2025
594,792
2026
471,756
Total undiscounted lease payments
2,994,348
Less: Imputed interest
1,484,488
Present value of lease payments
1,509,860
Add: carrying value of lease obligation at end of lease term
1,753,000
Total finance lease obligations
$ 3,262,860
Finance lease liabilities, current
$ 963,900
Finance lease liabilities, long-term
$ 2,298,960
Weighted-average discount rate
18.00 %
Weighted-average remaining lease term (months)
40.23
The
discount rate is the Company’s incremental borrowing rate, or the rate of interest that the Company would have to pay to borrow
on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Based on an assessment
of the Company’s borrowings at the time the finance leases were entered into, the incremental borrowing rate was determined to
be 18.00%.
Operating
Leases
Commencing
on September 15, 2019, the Company entered into a five-year lease with Jamboree Center 1 & 2 LLC covering approximately 6,961
square feet of office space in Irvine, CA. Under the terms of the lease agreement, we are required to make the following monthly lease
payments: Year 1 $ 21,927 , Year 2 $ 22,832 , Year 3 $ 23,737 , Year 4 $ 24,712 , Year 5 $ 25,686 . As a condition of the lease, we were required
to provide a $ 51,992 security deposit.
On
February 1, 2022, the Company entered into a lease agreement for approximately 2,533 square feet of office and manufacturing space
located in Las Vegas, Nevada. Commencing on March 1, 2022, the Company entered into a three-year lease with Speedway Commerce Center,
LLC. Under the terms of the lease agreement, we are required to make the following monthly lease payments: Year 1 $ 1,950 , Year 2 $ 2,028 ,
Year 3 $ 2,110 . As a condition of the lease, we were required to provide a $ 2,418 security deposit.
On
March 28, 2022, the Company entered into a lease agreement for approximately 1,469 square feet of office space located in Lehi,
Utah. Commencing on April 1, 2022, the Company entered into a three-year lease with Victory Holdings, LLC. Under the terms of the
lease agreement, we are required to make the following monthly lease payments: Year 1 is comprised of April to May 2022 $ 867 , June 2022
to March 2023 $ 3,550 , Year 2 $ 3,657 , Year 3 $ 3,766 . As a condition of the lease, we were required to provide a $ 3,766 security deposit.
On
April 1, 2022, the Company entered into a lease agreement for approximately 2,000 square feet of office and warehouse space located
in Houston, Texas. Commencing on April 1, 2022, the Company entered into a month-to-month lease with JVS Holdings, Inc. The lease
may be terminated at any time or for any reason with a 30-day written notice to terminate. The lease requires a monthly lease payment
of $ 2,000 as long as the Company remains in the space.
On
December 16, 2022, our subsidiary, VivaVentures Remediation Corp. entered into a Land Lease Agreement (the “Land Lease”)
with W&P Development Corporation, under which we agreed to lease approximately 3.5 acres of land in Houston, Texas. The Land Lease is for an initial term of 126 months
and may be extended for an additional 120 months at our discretion. Our monthly rent is $0 for the first three months and then at month
4 it is approximately $7,000 (based on a 50% reduction) and increases to approximately $13,000 in month 7 and then increases annually
up to approximately $16,000 per month by the end of the initial term. We plan to place one or more of our RPC machines on the property,
as well as store certain equipment.
The
right-of-use asset for operating leases as of December 31, 2022 and 2021 was $ 1,880,056 and $ 663,291 . Rent expense for the years
ended December 31, 2022 and 2021 was $ 404,383 and $ 292,410 .
F- 31
The
following table reconciles the undiscounted cash flows for the leases as of December 31, 2022 to the operating lease liability recorded
on the balance sheet:
Schedule of lessee operating lease liability
2023
$ 471,991
2024
435,906
2025
162,545
2026
136,975
2027
153,089
Thereafter
2,865,620
Total undiscounted lease payments
4,226,126
Less: Imputed interest
2,296,652
Present value of lease payments
$ 1,929,474
Operating lease liabilities, current
$ 471,991
Operating lease liabilities, long-term
$ 1,457,483
Weighted-average remaining lease term
209.88
Weighted-average discount rate
9.93 %
The
discount rate is the Company’s incremental borrowing rate, or the rate of interest that the Company would have to pay to borrow
on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Based on an assessment
of the Company’s borrowings at the time the operating leases were entered into, the incremental borrowing rate was determined to
be 9.93%.
Employment
Agreements
On
September 30, 2022, the Board of Directors of the Company received notice from Matthew Nicosia, the Company’s former
Chief Executive Officer and Chairman of the Board of Directors of his resignation from such positions. Such resignations are not the
result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices and the
resignation is considered to be without good reason. On October 28, 2022 we entered into an executive employment agreement with
a new Chief Executive Officer, James Ballengee, which provides for annual compensation of $1,000,000 payable in shares of our common
stock issued in four equal quarterly installments, priced at the volume weighted average price (VWAP) for the five trading days
preceding the date of the Employment Agreement and each anniversary thereof (the “CEO Compensation”). For the first
twelve months of Mr. Ballengee’s employment, we will issue him a total of 923,672 shares of our common stock, issuable 230,918
per quarter. The CEO Compensation shall be subject to satisfaction of Nasdaq rules, the provisions of the Company’s equity
incentive plan and other applicable requirements and shall be accrued if such issuance is due prior to satisfaction of such
requirements. Additionally, Mr. Ballengee shall be eligible for a discretionary performance bonus. The Employment Agreement may be
terminated by either party for any or no reason, by providing a five days’ notice of termination. In June 2022, the
Company entered into employment agreements with its previous Chief Executive Officer and its current Chief Financial Officer, which
provided for annual base salaries of $375,000 and $350,000, respectively, and provided for incremental increases in their salaries
upon the Company’s achievement of specific performance metrics. The Company is currently accruing substantial portions of
executive base salaries (see Note 14). The employment agreements provided for the grant of stock options to the previous Chief
Executive Officer and the current Chief Financial Officer to purchase up to 955,093 and 917,825 shares of the Company’s common
stock, respectively, at an exercise price equal to 110% and 100% of the fair market value of the Company’s common stock on the
date of grant. The previous Chief Executive Officer vested in 503,935
of these stock options before his resignation without good reason with the remainder of his stock options cancelled. The total stock
options for the former Chief Executive Officer vest over two years of continuous employment, subject to acceleration if terminated
without cause or resignations for good reason. The Chief Financial Officer’s agreement also provides that it is anticipated
that the executive will receive bonuses for 2022 which will be determined by the Company’s Compensation Committee and Board of
Directors after taking into account the general business performance of the Company, including any completed financings and/or
acquisitions.
F- 32
Note
18. Long-term Debt
To
assist in funding the manufacture of the Company’s Remediation Processing Centers, between 2015 and 2017, the Company entered into
two agreements which include terms for the purchase of participation rights for the sale of future revenue of the funded RPCs, and which
also require working interest budget payments by the Company.
The
Company accounts for the terms under these contracts for the sale of future revenue under Accounting Standards Codification 470 (“ASC
470”). Accordingly, these contracts include the receipt of cash from an investor where the Company agrees to pay the investor for
a defined period a specified percentage or amount of the revenue or a measure of income (for example, gross revenue) according to their
contractual right, in which the Company will record the cash as debt and apply the effective interest method to calculate and accrue
interest on the contracts. The terms of these agreements grant the holder a prorated 25% participation in the gross revenue of the assets
as defined in the agreements for 20 years after operations commence for a purchase price of approximately $2,200,000. The Company made
its first payment of $ 7,735 in the second quarter of 2021. The RPCs are estimated to enter
scaled up operations in 2023 and make estimated payments. The Company estimates future payments based on revenue projections for the
RPCs. Due to delays and limitations in achieving scaled up operations (see Note 3 Long Lived Assets ) the effective interest rate
of these agreements range from approximately 11% to 31% and 33% to 34% for the years ended December 31, 2022 and 2021.
In
accordance with ASC 470, the Company records the proceeds from these contracts as debt because the
Company has significant continuing involvement in the generation of the cash flows due to the investor (for example, active involvement
in the generation of the operating revenues of the business segment), which constitutes the presence of a factor that independently creates
a rebuttable presumption that debt classification is appropriate. The Company has determined its effective interest rates to be between
approximately 11% and 34% based on each contract’s future revenue streams expected to be paid to the investor as of December 31,
2022. These rates represent the discount rate that equates estimated cash flows with the initial proceeds received from the investor
and is used to compute the amount of interest expense to be recognized each period. During the development and manufacturing of the assets
the effective interest has been capitalized to the assets. As the assets enter operations or service of their intended use, the effective
interest on these contracts will be recognized as interest expense (see Note 11).
In
2016 and 2017, additional consideration to investors to enter into these agreements was granted, and the Company issued to these investors
113,000 shares of Series B-1 Preferred Stock with a relative fair value of $7.50 per share or based on conversion terms and price of
the Company’s Common Stock at the time of issuance. The Company also issued 106,167 common stock warrants to investors. The relative
fair value of the warrants and Series B-1 preferred stock in aggregate was $ 1,488,550 , and was recorded as a debt discount, which is
amortized to interest expense over the term of the agreements using the effective interest method. During the manufacturing phase of
the asset, the interest expense is capitalized to the asset.
Some
holders of these participation rights also have the option to relinquish ownership and all remaining benefits of their LLC units in exchange
for Common Stock in the Company. Depending on the contract, these options to convert to common stock range from between 1 and 5.5 years.
The exercise period ranges from between 1 year to 5.5 years with a step-up discount to market for each year the option is not exercised
with a range of between a 5% to a 25% discount to market. As of December 31, 2022 and 2021 none of these options have been exercised to convert to Common Stock. Accordingly, under Accounting Standards Codification 815 (“ASC 815”)
the Company valued these options at fair value using a Monte Carlo Simulation by a third-party valuation expert, which found the fair
value of the options to be nominal. Long-term debt related to these participation rights is recorded in “Long-term debt”
on the consolidated balance sheet.
The
accounting for the terms under these contracts that call for working interest budget payments by the Company are recorded in current
liabilities on the consolidated balance sheet and paid down through pass-through expenses or cash according to the contract. Accordingly,
the Company records any unpaid balance of budget payments received in “Long-term debt, current” as these liabilities are
generally paid within 12 months after proceeds are received.
F- 33
Long-term
debt consists of the following:
Schedule Of Long-Term Debt
December 31,
2022
2021
Principal
$ 2,196,233
$ 2,196,233
Accrued interest
1,922,621
4,205,144
Debt discount
( 211,938 )
( 226,823 )
Total long-term debt
$ 3,906,916
$ 6,174,554
Long term debt, current
$ 9,363
$ 3,256
Long term debt
$ 3,897,553
$ 6,171,298
The
following table sets forth the estimated payment schedule of long-term debt as of December 31, 2022:
Schedule of long-term debt maturities
2023
$ 11,134
2024
28,361
2025
34,324
2026
40,113
2027
47,141
Thereafter
2,035,159
Total
$ 2,196,233
Note
19. Stockholders’ Equity
Series
A, Series B, Series B-1, Series C and Series C-1 Preferred Stock
The
Preferred Stock authorized by the Company may be issued from time to time in one or more series. The Company is authorized to issue 15,000,000
shares of preferred stock. The Company is authorized to issue 66,667 shares of Series A Preferred Stock, 3,266,667 shares of Series B
Preferred Stock, 1,666,667 shares of Series B-1 Preferred Stock, 3,333,333 shares of Series C Preferred Stock, and 3,333,333 shares of
Series C-1 Preferred Stock. The Board of Directors is authorized to fix or alter the number of shares constituting any series of Preferred
Stock and the designation thereof. In 2021, the Board of Directors authorized, and a majority vote acceptance was received of each voting
class of preferred stock, including Series B Preferred Stock, Series B-1 Preferred Stock, and Series C-1 Preferred Stock, that each class’s
designations be amended that upon the Company’s public offering in conjunction with an uplist to a senior stock exchange that these
classes of preferred stock will convert their preferred shares to common shares on a one for one basis.
The
Company has no issued and outstanding shares of Series A Preferred as of December 31, 2022. All of the outstanding shares of Series
A Preferred Stock (66,667 shares) were converted to common stock upon the close of the Company’s public offering of the Company’s
common stock on February 14, 2022. The conversion price is subject to adjustment under certain customary circumstances, including
as a result of stock splits and combinations, dividends and distributions, and certain issuances of common stock. Holders of shares of
Series A Preferred Stock will have the right to 25 votes for each share of Common Stock into which such shares of Series A Preferred
Stock can then be converted (with a current conversion ratio of 10 shares of Common Stock for each outstanding share of Series A Preferred
Stock) and the right to a liquidation preference in any distribution of net assets made to the shareowners prior to and in preference
to the holders of Common Stock and any other Preferred Stock holder in the liquidation, dissolution or winding up of our Company. As
of December 31, 2022 and 2021 the liquidation preference was none and $ 400,000 . Holders of shares of Series A Preferred Stock are
not currently entitled to dividends. The Company has the right, but not the obligation, to redeem shares of Series A Preferred Stock.
F- 34
The
Company has no issued outstanding shares of Series B Preferred Stock as of December 31, 2022 and 2021, respectively. Shares of Series
B Preferred Stock are convertible one year after issuance, at any time at the option of the holder, into shares of Common Stock (with
a conversion price at the lesser of the issuance price ($6.00) or a 10% discount to market on the conversion date). Automatic 1-for-1
conversion of all outstanding shares of Series B Preferred Stock into shares of Common Stock occurred on May 1, 2021. No other shares
have been issued since the conversion of all of the outstanding shares of this class of stock. The conversion price is subject to adjustment
under certain customary circumstances, including as a result of stock splits and combinations, dividends and distributions, and certain
issuances of common stock. The Company has the right, but not the obligation, to redeem shares of Series B Preferred Stock one year after
issuance. Holders of Series B Preferred Stock will have the right to one vote for each share of Common Stock into which such Series B
Preferred Stock is then convertible, and a right to a liquidation preference in any distribution of net assets made to the shareowners
prior to and in preference to the holders of Common Stock and any Preferred Stockholder, except holders of Series A Preferred Stock,
in the liquidation, dissolution or winding up of our Company. Dividends are 12.5 % and cumulative and are payable only when, as, and if
declared by the Board of Directors.
The
Company has no issued and outstanding shares of Series B-1 Preferred Stock as of December 31, 2022 and 2021, respectively. Shares
of Series B-1 Preferred Stock are convertible one year after issuance, at any time at the option of the holder, into shares of Common
Stock (with a conversion price at the lesser of the issuance price ($7.50) or a 10% discount to market on the conversion date). Automatic
1-for-1 conversion of all outstanding shares of Series B-1 Preferred Stock into shares of Common Stock occurred on May 1, 2021.
No other shares have been issued since the conversion of all of the outstanding shares of this class of stock. The conversion price is
subject to adjustment under certain customary circumstances, including as a result of stock splits and combinations, dividends and distributions,
and certain issuances of common stock. The Company has the right, but not the obligation, to redeem shares of Series B-1 Preferred Stock
one year after issuance. Holders of Series B-1 Preferred Stock have no voting or dividend rights, and a right to a liquidation preference
in any distribution of net assets made to the shareowners prior to and in preference to the holders of Common Stock and any Preferred
Stockholder, except holders of Series A and Series B Preferred Stock, in the liquidation, dissolution or winding up of our Company.
The
Company has not issued any Series C Preferred Stock as of December 31, 2022 and 2021, respectively. Shares of Series C Preferred
Stock are convertible one year after issuance, at any time at the option of the holder, into shares of Common Stock (with a conversion
price at the lesser of the issuance price ($10.50) or a 10% discount to the market price on the conversion date). Automatic conversion
of shares of Series C Preferred Stock into shares of Common Stock may occur due to certain qualified public offerings entered into or
by written consent of a majority of the holders of Series C Preferred Stock or upon the four-year anniversary date of the issuance of
such shares. The conversion price is subject to adjustment under certain customary circumstances, including as a result of stock splits
and combinations, dividends and distributions, and certain issuances of common stock. The Company has the right, but not the obligation,
to redeem shares of Series C Preferred Stock one year after issuance. Holders of Series C Preferred Stock will have the right to one
vote for each share of Common Stock into which such Series C Preferred Stock is then convertible, and a right to a liquidation preference
in any distribution of net assets made to the shareowners prior to and in preference to the holders of Common Stock and any Preferred
Stockholder, except holders of Series B and B-1 Preferred Stock, in the liquidation, dissolution or winding up of our Company. Dividends
are 12.5 % and cumulative and are payable only when, as, and if declared by the Board of Directors.
The
Company has no issued and outstanding shares of Series C-1 Preferred Stock as of December 31, 2022 and 2021, respectively. Shares
of Series C-1 Preferred Stock are convertible one year after issuance, at any time at the option of the holder, into shares of Common
Stock (with a conversion price at the lesser of the issuance price ($12.00) or a 10% discount to the market price on the conversion date).
Automatic conversion of all outstanding shares of Series C-1 Preferred Stock into shares of Common Stock occurred on May 4, 2021
by written consent of a majority of the holders of Series C-1 Preferred Stock. No other shares have been issued since the conversion
of all of the outstanding shares of this class of stock. The conversion price is subject to adjustment under certain customary circumstances,
including as a result of stock splits and combinations, dividends and distributions, and certain issuances of common stock. The Company
has the right, but not the obligation, to redeem shares of Series C-1 Preferred Stock one year after issuance. Holders of Series C-1
Preferred Stock have no voting or dividend rights, and a right to a liquidation preference in any distribution of net assets made to
the shareowners prior to and in preference to the holders of Common Stock and any Preferred Stockholder, except holders of Series A,
Series B, Series B-1, and Series C Preferred Stock, in the liquidation, dissolution or winding up of our Company.
F- 35
On
February 14, 2022, we effected a 1-for-30 reverse split of our authorized and outstanding shares via the filing of a certificate
of change with the Nevada Secretary of State, which was filed simultaneously with the close of the underwritten public offering of our
common stock and the commencement of the trading of our common stock on the Nasdaq Capital Market, LLC. As a result of the reverse stock
split, all authorized and outstanding common stock, preferred stock, and per share amounts have been adjusted to reflect the reverse
stock split for all periods presented.
For
the year ended December 31, 2022, all of the outstanding shares of Series A Preferred Stock ( 66,667 shares) were converted to common
stock upon the close of the Company’s public offering of the Company’s common stock on February 14, 2022, and converted
into 833,333 shares of Common Stock.
For
the year ended December 31, 2021, $ 9,467,604 or 950,972 shares of Series B, Series B-1, and Series C-1 Preferred Stock were converted
into 955,947 shares of Common Stock.
For
the year ended December 31, 2021, the Company issued 5,413 Series C-1 Preferred Stock or $ 64,950 for a reduction in stock payables.
For
the year ended December 31, 2021, the Company issued 5,626 shares of Series B-1 Preferred Stock as a $ 42,196 stock dividend paid
to Series B Preferred Shareholders.
Common
Stock
The
Company is authorized to issue 41,666,667 shares of common stock. As of December 31, 2022 and 2021, there were 18,064,838 and 12,330,859
shares of our common stock issued and outstanding, respectively. Treasury stock is carried at cost.
On
February 14, 2022, we closed an underwritten public offering for 1,600,000 shares of common stock, at a public offering price
of $5.00 per share, for aggregate net proceeds of $6.2 million, after deducting underwriting discounts, commissions, and
other offering expenses of approximately $1.8 million. We effected a 1-for-30 reverse split of our authorized and outstanding shares
of common stock (the “Reverse Stock Split”) via the filing of a certificate of change with the Nevada Secretary of
State, which was filed simultaneously with the close of the underwritten public offering of our common stock and the commencement of
the trading of our common stock on the Nasdaq Capital Market, LLC. As a result of the Reverse Stock Split, all authorized and
outstanding common stock, preferred stock, and per share amounts have been adjusted to reflect the Reverse Stock Split for all
periods presented.
On
August 1, 2022, we closed a Membership Interest Purchase Agreement, (the “MIPA”), with Jorgan Development, LLC, (“Jorgan”)
and JBAH Holdings, LLC, (“JBAH”), as the equity holders of Silver Fuels Delhi, LLC (“SFD”) and White Claw Colorado
City, LLC (“WCCC”), whereby, the Company acquired all of the issued and outstanding membership interests in each of SFD and
WCCC, making SFD and WCCC wholly owned subsidiaries of the Company. The purchase price for the Membership Interests is approximately
$ 32.9 million, after post-closing adjustments, payable in part by the issuance of 3,009,552 shares of the Company’s common stock,
amount equal to 19.99 % of the number of issued and outstanding shares of the Company’s common stock immediately prior to closing.
JBAH and Jorgan have entered into 18-month lock-up agreements to the 3,009,552 common shares issued for consideration (see Note 4).
For
the year ended December 31, 2021, $ 9,467,604 or 950,972 shares of Series B, Series B-1, and Series C-1 Preferred Stock were converted
into 955,947 shares of Common Stock.
F- 36
For
the years ended December 31, 2022 and 2021, the Company issued 272,156 and 68,611 common shares for a $ 1,144,992 and $ 495,799 reduction
of liabilities.
For
the years ended December 31, 2021, the Company issued 33,667 shares of Common Stock for $ 438,004 in services to the Company.
For
the year ended December 31, 2021, the Company issued 16,667 shares for a $ 225,000 payment for a technology license (see Note 10).
Noncontrolling
Interest
For
the years ended December 31, 2022 and 2021, the Company converted $ 4,865,000 and $ 5,560,000 in Viva Wealth Fund I, LLC convertible
promissory notes into 973 and 1,112 units of noncontrolling interest in Viva Wealth Fund I, LLC, and paid distributions to unit holders
of $ 861,691 and $ 55,050 .
Note
20. Temporary Equity
Shares
of Series B, B-1, C and C-1 convertible preferred stock hold conversion features providing that, at the holder’s election, the
holder may convert the preferred stock into common stock. Upon conversion, the Company may be required to deliver a variable number of
equity shares that is determined by using a formula based on the market price of the Company’s Common Stock. After four years from
the date of issuance, Series C preferred shareholders are forced to automatically convert to Common Stock. On May 1, 2021, all outstanding
shares of Series B and B-1 converted at 1-for-1 to Common Stock. On May 4, 2021, all outstanding shares of Series C-1 converted
at 1-for-1 to Common Stock. For each respective series, the holder may convert their preferred shares to common shares at the original
issue price as defined, which ranges from between $6.00 per share to $12.00 per share, at the lesser of the original issue price or 90%
of the market price on the conversion date. There is no contractual cap on the number of common shares that the Company could be required
to deliver on preferred shareholders’ conversions to Common Stock.
Accordingly,
under ASC 815-40-25-10 the Company may be forced to settle these conversion features in cash, specifically since it is unknown as to
what date the shareholders’ may convert their preferred stock to common stock and if there will be sufficient authorized and unissued
common shares on that date. As of December 31, 2020 the Company did have sufficient authorized and unissued common shares to satisfy
all preferred shareholders interest if it were converted to Common Stock, although if the stock price were to drop below $0.60 per share
and the Company may be forced to settle such conversions in cash, which may consider them redeemable. Accordingly, Series B, B-1, C and
C-1 preferred stock has been classified in temporary equity until later converted into common shares in 2021.
The
following table shows all changes to temporary equity during for the years ended December 31, 2021.
Schedule Of Temporary Equity
Convertible Preferred Stock
Series B
Series B-1
Series C-1
Shares
Amount
Shares
Amount
Shares
Amount
December 31, 2020
216,916
$ 1,301,500
467,728
$ 3,507,981
255,290
$ 4,550,977
Series C-1 Issue for a reduction in stock payables
-
-
-
-
5,413
64,950
Dividend paid in Series B-1 Preferred Stock
-
-
5,626
42,196
-
-
Conversion of Series B and B-1 Preferred Stock to Common Stock
( 216,916 )
( 1,301,500 )
( 473,354 )
( 3,550,177 )
( 260,703 )
( 4,615,927 )
December 31, 2021
-
$ -
-
$ -
-
$ -
F- 37
Note
21. Share-Based Compensation & Warrants
On February 14, 2022, our 2021 Equity and
Incentive Plan (the Plan) went effective. The plan was approved by our Board of Directors.
The following is a summary
of the material features of the Plan, which is qualified in its entirety by reference to the actual text of the Plan.
Eligibility. The Plan
provides for the grant of equity awards to the officers, employees, directors, consultants and other key persons of the Company and our
subsidiaries selected from time to time by our Compensation Committee of the Board. The Compensation Committee will determine in its sole
and absolute discretion the specific individuals eligible to participate in the Plan. As of April 14, 2023, we had approximately ten employees
and five directors. The Company also employs consultants to supplement its operational activities.
Awards. Awards under
the Plan may take the form of stock options, stock appreciation rights (“SARs”), restricted stock awards, unrestricted stock
awards, restricted stock units (“RSUs”), and other share-based awards, or any combination of the foregoing (each, an “award”
and collectively, “awards”).
Shares Available. Subject
to the adjustment provisions discussed below under “Adjustments,” the total number of shares that may be issued under the
Plan is 2,000,000 .
Plan Administration.
Our Compensation Committee of the Board will administer the Plan at the time we add additional independent directors. Until then the Board
will administer the Plan. The Board and the Compensation Committee are to as the “Administrator.” The Administrator will be
authorized to grant awards under the Plan, to interpret the provisions of the Plan and to prescribe, amend and rescind rules relating
to the Plan or any award thereunder. It is anticipated that the Administrator (either generally or with respect to specific transactions)
will be constituted so as to comply, as necessary or desirable, with the requirements of Section 162(m) of the Internal Revenue Code
(the “Code”) and Rule 16b-3 promulgated under the Exchange Act.
Stock Options. The Plan
permits the granting of “incentive stock options” meeting the requirements of Section 422 of the Code, and “nonqualified
stock options” that do not meet such requirements. The term of each option is determined by the Compensation Committee and shall
not exceed ten years after the date of grant. Options may also be subject to restrictions on exercise, such as exercise in periodic installments,
as determined by the Administrator. In general, the per share exercise price for options must be at least equal to 100% of the fair market
value of the underlying shares on the date of the grant, unless the option is intended to be compliant with the requirements of Section 409A
of the Code. All 2,000,000 shares authorized for issuance under the Plan shall be available for issuance in respect of incentive stock
options.
Stock Appreciation Rights.
The Plan permits the granting of SARs. The Administrator will determine any vesting schedules and the terms and conditions of each grant.
Upon the exercise of a SAR, the recipient is entitled to receive from the Company an amount in cash or shares with a fair market value
equal to the appreciation in the value of the shares subject to the SAR over a specified reference price. The reference price per share
of any SAR will not be less than 100% of the fair market value per share of Company Common Stock on the date of the grant of the SAR,
unless the SAR is intended to be compliant with the requirements of Section 409A of the Code.
Restricted Stock Awards.
The Administrator may award restricted stock under the Plan. Restricted stock gives a participant the right to receive stock subject to
a risk of forfeiture based upon certain conditions. The forfeiture restrictions on the shares may be based upon performance standards,
length of service and/or other criteria as the Compensation Committee may determine. Until all restrictions are satisfied, lapsed or waived,
we will maintain custody over the restricted stock, but the participant will be able to vote the shares and will be entitled to all distributions
paid with respect to the shares (but see below, under the heading “No Current Dividends on Unvested Awards” with respect to
the treatment of dividends while the shares remain unvested). During the period in which shares are restricted, the restricted stock may
not be sold, assigned, transferred, pledged or otherwise encumbered. Upon termination of employment, the participant will forfeit the
restricted stock to the extent the applicable vesting requirements have not by then been met.
Unrestricted Stock Awards.
The Administrator may award unrestricted stock under the Plan. Unrestricted stock may be granted in respect of past services or other
valid consideration, or in lieu of cash compensation due to such grantee.
F- 38
Restricted Stock Units.
The Plan provides that the Administrator may grant restricted stock units (“RSUs”), which represent the right to receive shares
following the satisfaction of specified conditions. The Administrator will determine any vesting schedules and the other terms of each
grant of RSUs. A participant will not have the rights of a stockholder with respect to the shares subject to an RSU award prior to the
actual issuance of those shares.
Performance Awards. The
Plan provides that the Administrator may grant awards that are contingent upon the achievement of specified performance criteria (“Performance
Awards”). Such awards may be payable in cash, shares or other property. The Administrator will determine the terms of Performance
Awards, including the performance criteria, length of the applicable performance period, and the time and form of payment.
Other Share-Based Awards.
The Plan provides that the Administrator may grant other awards that are payable in, valued in whole or in part by reference to, or otherwise
based on or related to shares. All the terms of such other share-based awards will be determined by the Administrator.
No Payment of Dividends
Until Awards Vest. Dividends or dividend equivalents payable with respect to Plan awards will be subject to the same vesting terms as
the related award.
Adjustments. In the event
of any corporate transaction or event such as a stock dividend, extraordinary dividend or similar distribution (whether in the form of
cash, shares, other securities, or other property), reorganization, recapitalization, reclassification, stock dividend, stock split, reverse
stock split or other similar change in the Company’s capital stock, the Plan provides that the Administrator will make equitable
adjustments to (i) the maximum number of shares reserved for issuance under the Plan, (ii) the number and kind of shares or other securities
subject to any then outstanding awards under the Plan, (iii) the repurchase price, if any, per phare subject to each outstanding award,
and (iv) the exercise price for each Share subject to any then outstanding Stock Options under the Plan, without changing the aggregate
exercise price (i.e., the exercise price multiplied by the number of Stock Options) as to which such Stock Options remain exercisable.
Transferability of Awards.
Restricted Stock awards, Stock Options, SARs and, prior to exercise, the shares issuable upon exercise of such Stock Option shall not
be transferred other than by will, or by the laws of descent and distribution. The Administrator, however, may allow for the assignment
or transfer of an award (other than incentive stock options and restricted stock awards) to a participant’s spouse, children and/or
trusts, partnerships, or limited liability companies established for the benefit of the participant’s spouse and/or children, subject
in each case to certain conditions on assignment or transfer.
Termination and Amendment.
The Board may, at any time, amend or discontinue the Plan and the Compensation Committee may, at any time, amend or cancel any outstanding
award for the purpose of satisfying changes in law or for any other lawful purpose, but no such action shall adversely affect rights under
any outstanding award without the consent of the holder of the Award. The Compensation Committee may exercise its discretion to reduce
the exercise price of outstanding Stock Options or effect repricing through cancellation of outstanding Stock Options and by granting
such holders new awards in replacement of the cancelled Stock Options. To the extent determined by the Compensation Committee to be required
either by the Code to ensure that Incentive Stock Options granted under the Plan are qualified under Section 422 of the Code or otherwise,
Plan amendments shall be subject to approval by the Company stockholders entitled to vote at a meeting of stockholders. The Board has
the right to amend the Plan and/or the terms of any outstanding Stock Options to the extent reasonably necessary to comply with the requirements
of the exemption pursuant to Rule 12h-1 of the Exchange Act.
Treatment of Awards Upon
a Sale Event. In the case of and subject to the consummation of a Sale Event (as the term is defined in the Plan), the Plan and all outstanding
Stock Options and SARs issued thereunder shall become one hundred percent (100%) vested upon the effective time of any such Sale Event,
all unvested Restricted Stock and unvested Restricted Stock Unit Awards issued thereunder shall become one hundred percent (100%) vested,
with an equitable or proportionate adjustment as to the number and kind of shares subject to such awards as such parties shall agree,
and such Restricted Stock shall be repurchased from the holder thereof at the then fair market value of such shares. In the event of the
termination of the Plan, each holder of Stock Options shall be permitted, within a period of time prior to the consummation of the Sale
Event as specified by the Administrator, to exercise all such Stock Options or SARs which are then exercisable or will become exercisable
as of the effective time of the Sale Event.
F- 39
Treatment of Termination
of Service Relationship. Any portion of a Stock Option or SAR that is not vested and exercisable on the date of termination of an optionee’s
service relationship, a grantee’s right in all Restricted Stock Units that have not vested upon the grantee’s cessation of
service relationship with the Company and any subsidiary for any reason, shall immediately expire and be null and void, unless otherwise
be provided by the Administrator. Once any portion of the Stock Option becomes vested and exercisable, the optionee’s right to exercise
such portion of the Stock Option or SAR in the event of a termination of the optionee’s service relationship shall continue until
the earliest of: (i) the date which is: (A) 12 months following the date on which the optionee’s Service Relationship terminates
due to death or Disability (or such longer period of time as determined by the Committee and set forth in the applicable Award Agreement),
or (B) three months following the date on which the optionee’s Service Relationship terminates if the termination is due to any
reason other than death or Disability (or such longer period of time as determined by the Committee and set forth in the applicable Award
Agreement), or (ii) the expiration date set forth in the award agreement; provided that notwithstanding the foregoing, an award agreement
may provide that if the optionee’s rervice Relationship is terminated for cause, the Stock Option shall terminate immediately and
be null and void upon the date of the optionee’s termination and shall not thereafter be exercisable.
Tax Withholding. The
Company and its subsidiaries may deduct amounts from participants to satisfy withholding tax requirements arising in connection with
Plan awards. The Company’s obligation to deliver stock certificates (or evidence of book entry) to any grantee is subject to and
conditioned on any such tax withholding obligations being satisfied by the grantee.
Options
Generally
accepted accounting principles require share-based payments to employees, including grants of employee stock options, warrants, and common
stock to be recognized in the income statement based on their fair values at the date of grant, net of estimated forfeitures.
The Company has granted stock-based compensation to employees, including a 16,667 share stock award,
which was issued in 2018 and vested in May 2022, 166,667 in employee stock options that were issued in 2020 to cliff vest at the
end of five years, but were cancelled on September 1, 2022 by the parties in conjunction with the issuance of 1,872,918 employee
stock options granted in June 2022 that were to vest over a period of two years, for which 451,158 of these options were cancelled
with the resignation without cause in October 2022 of our prior Chief Executive Officer. For the years ended December 31, 2022
and 2021, stock-based compensation was $ 2,606,703 and $ 446,112 . In 2020, the Company also granted non-statutory stock options, including
133,333 stock options to the Board of Directors, which vested over 1 year, and a 333,334 stock option to a consultant, which was to vest
over 4 years, but was cancelled on September 1, 2022 by the parties which concluded that it was not probable that certain performance
targets would be met, as agreed upon by both parties. On October 24, 2022, the Board of Directors resolved to increase their compensation including the issuance of 100,000 stock options per independent board member, exercisable at $ 2.50 per share, vesting immediately. Non-statutory stock-based compensation was $ 1,472,888 and $ 1,585,000 for the years
ended December 31, 2022 and 2021. In 2022, the Company closed on its underwritten public offering in which the Company granted the
underwriter, EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”), a 45-day option to purchase up to an additional
240,000 shares of Common Stock at the public offering price per share, less the underwriting discounts and commissions, to cover over-allotments,
if any. These options were not exercised and expired.
There
were no other options granted during the years ended December 31, 2022 and 2021, respectively.
The
assumptions used in the Black-Scholes option pricing model to determine the fair value of the options on the date of issuance are as
follows:
Schedule
of option activity
December 31,
2021
through
December 31, 2022
Risk-free interest rate
0.24 4.57 %
Expected dividend yield
None
Expected life of warrants
3.33 - 10 years
Expected volatility rate
156 - 273 %
F- 40
The
following table summarizes all stock option activity of the Company for the years ended December 31, 2022 and 2021:
Schedule
of warrant assumptions
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (Years)
Outstanding, December 31, 2020
650,000
$ 12.00
8.53
Granted
-
-
-
Exercised
-
-
-
Forfeited
-
-
-
Outstanding, December 31, 2021
650,000
$ 12.00
7.53
Granted
2,412,918
2.28
5.78
Exercised
( 16,667 )
11.10
-
Forfeited
( 1,212,685 )
7.05
-
Outstanding, December 31, 2022
1,833,566
$ 2.59
6.47
Exercisable, December 31, 2021
180,000
$ 12.00
7.01
Exercisable, December 31, 2022
1,526,869
$ 2.65
5.94
As
of December 31, 2022 and 2021, the aggregate intrinsic value of the Company’s outstanding options was approximately none.
The aggregate intrinsic value will change based on the fair market value of the Company’s common stock.
Warrants
As
of December 31, 2022 and 2021, the Company had 80,000 and no warrants outstanding. On February 14, 2022, the Company closed
on its underwritten public offering of 1,600,000 shares of common stock, at a public offering price of $5.00 per share. In addition,
the Company has issued the underwriter, EF Hutton, a 5-year warrant to purchase 80,000 shares of common stock at an exercise price equal
$ 5.75 . and were valued with a fair market value of $ 374,000 . The impact of these warrants has no effect on stockholder’s equity,
as they are considered equity-like instruments, and are considered a direct expense of the offering.
Management
uses the Black-Scholes option pricing model to determine the fair value of warrants on the date of issuance.
The
assumptions used in the Black-Scholes option pricing model to determine the fair value of the warrants on the date of issuance are as
follows:
Schedule of warrant activity
Risk-free interest rate
1.92 %
Expected dividend yield
None
Expected life of warrants
5 years
Expected volatility rate
167 %
F- 41
Note
22. Income Tax
Benefit for income taxes is as follows:
Schedule of components of income tax
December 31,
2022
2021
Current :
State
$ 800
$ 800
Total current
800
800
Deferred :
Federal
( 3,082,578 )
( 718,868 )
State
( 1,354,913 )
( 332,139 )
Total Deferred
( 4,437,491 )
( 1,051,007 )
Net provision
$ ( 4,436,691 )
$ ( 1,050,207 )
The differences between the expected income tax benefit based on the statutory Federal United States income tax rates and the Company’s effective tax rates are summarized
below:
Schedule
reconciliation of income tax
December 31,
2022
Tax Computed At The Federal Statutory Rate
$ ( 4,985,329 )
21.00 %
State Tax, Net Of Fed Tax Benefit
( 1,312,478 )
5.53 %
Nondeductible Expenses
515,476
- 2.17 %
Flowthrough Entity not Subject to Tax
422,216
- 1.78 %
Foreign Corporation - Minority Interest
6,201
- 0.03 %
Other
92,854
- 0.39 %
Valuation Allowance
824,368
- 3.47 %
Benefit
for income taxes
$ ( 4,436,691 )
18.69 %
December 31,
2021
Tax Computed At The Federal Statutory Rate
$ ( 1,338,184 )
21.00 %
State Tax, Net Of Federal Tax Benefit
( 263,892 )
4.14 %
Nondeductible Expenses
85,025
- 1.33 %
Flowthrough Entity not Subject to Tax
454,587
- 7.13 %
Foreign Corporation - Minority Interest
3,140
- 0.05 %
Valuation Allowance
9,117
- 0.14 %
Benefit for income taxes
$ ( 1,050,207 )
16.48 %
F- 42
Significant
components of the Company’s deferred tax assets and liabilities are as follows:
Schedule of deferred tax assets and liabilities
December 31,
2022
Reserves
$ 572,650
Fixed Assets
( 1,747,971 )
Leases
( 3,312 )
Intangibles
( 2,302,728 )
Net Operating Losses
4,253,740
Impairment Losses
3,117,046
Stock Options
( 129,350 )
Accruals
1,011,016
Other
( 231,111 )
Net Deferred Asset
4,539,981
Less: Valuation Allowance
( 4,539,981 )
Total deferred tax liability:
$ -
December 31,
2021
Reserves
$ 336,875
Fixed Assets
( 1,915,092 )
Leases
16,395
Intangibles
( 3,622,638 )
Net Operating Losses
3,553,164
Impairment Losses
-
Stock Options
598,849
Accruals
( 32,905 )
Other
( 393,154 )
Net Deferred Liability
( 1,458,506 )
Less: Valuation Allowance
( 3,698,393 )
Total deferred tax liability:
$ ( 5,156,899 )
In
determining the possible future realization of deferred tax assets, the Company has considered future taxable income from the following
sources: (a) reversal of taxable temporary differences; and (b) tax planning strategies that, if necessary, would be implemented to accelerate
taxable income into years in which net operating losses might otherwise expire.
F- 43
Deferred
tax assets are recognized subject to management’s judgment that realization is more likely than not. A valuation allowance is recognized
for a deferred tax asset if, based on the weight of the available evidence, it is more likely than not that some portion of the deferred
tax asset will not be realized. In making such judgments, significant weight is given to evidence that can be objectively verified. Based
on our review of the deferred tax assets the Company has concluded that a valuation allowance is necessary on the net operating loss
balance, as realization of this asset does not meet the more likely than not threshold.
As of December 31, 2022 and 2021, the Company
had estimated net operating losses for federal and state purposes of $ 23.7 and $ 14.3 million, respectively. Federal and state net operating
losses will begin to expire in 2028.
We recognize a tax position as a benefit only
if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being
presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination.
For tax positions not meeting the “more
likely than not” test, no tax benefit is recorded. We recognize potential interest and penalties related to unrecognized tax benefits
in the general and administrative expense in the statement of operations of the Company.
The Company is in the process of filing back income
tax returns from 2010 through the current year and subject to IRS examination for these years. The Company has booked a reserve for potential
penalties associated with non-filing of certain foreign information reports related to its subsidiary in the Middle East. Penalties and
interest have been reported in the general and administrative section of the statement of operations. The reserve balance at December 31,
2022 and 2021 was $ 517,000 and $ 289,000 , respectively. The Company does not expect this reserve to reverse within the next 12 months,
as they will apply for a penalty waiver when the tax returns are ultimately filed. Due to the non-filing of income tax returns, statutes
of limitations on the potential examination of those income tax periods will continue to run until the returns are filed, at which time
the statutes will begin. The Company expects to file all past due income tax returns within the next 12 months.
Note
23. Related Party Transactions
On
October 24, 2022, the Board of Directors resolved to increase their compensation to (i) $50,000 per year in cash effective August 1,
2022, in equal quarterly payments, with the first such payment, in the amount of $12,500 due November 1, 2022 and, thereafter, $12,500
every February 1, May 1, August 1 and November 1, and (ii) 100,000 stock options priced at $2.50 per share, vesting
immediately. In addition, the Board of Directors approved a one-time payment of $10,000 to each Mr. Trent Staggs and Mr. Al Ferrara for
serving as the Chairperson of the Compensation Committee and Chairperson of the Audit Committee of the Board of Directors, respectively,
payable on November 1, 2022. Al Ferrara resigned from the Audit Committee and Board of Directors on November 28, 2022. Trent
Staggs resigned from the Compensation Committee and the Board of Directors on January 4, 2023. Matthew Balk resigned from the Board
of Directors on January 16, 2023.
F- 44
Viva
Wealth Fund I, LLC (VWFI), which is managed by Wealth Space LLC, has continued its private offering of up to $ 25,000,000 in convertible
notes for the manufacture of one or more RPC machines. As of December 31, 2022, VWFI has raised $ 11,750,000 . As of December 31,
2022, VWFI has paid $ 2,266,964 to Dzign Pro Enterprises, LLC (Dzign Pro) for engineering services related to our RPCs, site planning,
and infrastructure, which entity shares a common executive with VWFI. As of December 31, 2022, VWFI also entered into a master revolving
note payable to Dzign Pro in the amount of $ 300,000 , which accrues 5% interest per annum, has a maturity date of July 14, 2024,
where no payments are made prior to the maturity date unless at the option of the fund. VWFI also entered into a master revolving note
payable to Van Tran Family LP, which is an affiliate of WealthSpace, LLC, the VWFI Fund Manager, in the amount of $599,500, which accrues
6% interest per annum, has a maturity date of October 11, 2023, where no payments are made prior to the maturity date unless at
the option of the fund.
On
June 15, 2022, we entered into a Membership Interest Purchase Agreement (the “MIPA”), with Jorgan Development, LLC,
(“Jorgan”) and JBAH Holdings, LLC, (“JBAH” and, together with Jorgan, the “Sellers”), as the equity
holders of Silver Fuels Delhi, LLC (“SFD”) and White Claw Colorado City, LLC (“WCCC”) whereby, at closing, which
occurred on August 1, 2022, we acquired all of the issued and outstanding membership interests in each of SFD and WCCC (the “Membership
Interests”), making SFD and WCCC our wholly-owned subsidiaries. The purchase price for the Membership Interests was approximately
$32.9 million paid for by us with a combination of shares of our common stock, amount equal to 19.99% of the number of issued and outstanding
shares of our common stock immediately prior to issuance, and secured three-year promissory notes issued by us in favor of the Sellers
(the “Notes”). The principal amount of the Notes, together with any and all accrued and unpaid interest thereon, will be
paid to the Sellers on a monthly basis in an amount equal to the Monthly Free Cash Flow beginning on August 20, 2022, and continuing
thereafter on the twentieth (20 th ) calendar day of each calendar month thereafter, as set forth in the MIPA. At the time of
the closing of these transactions Jorgan, JBAH, and our newly hired CEO, James Ballengee were not considered related parties. As James
Ballengee is now our Chief Executive Officer and is the beneficiary of Jorgan and JBAH, and the Sellers now own approximately 16.66%
of our outstanding common shares, certain transactions, as noted below, related to Jorgan, JBAH, and James Ballengee are now considered
related party transactions.
The
consideration for the membership interests included the Notes in the amount of $ 286,643 to JBAH and $ 28,377,641 to Jorgan, which accrue
interest of prime plus 3% on the outstanding balance of the notes. Under the MIPA, we have committed to make a payment to Jorgan and
JBAH on or before February 1, 2024 in the amounts of $16,306,754 to Jorgan and $164,715 to JBAH, whether in cash or unrestricted
common stock. In the event of a breach of the terms of the Notes, the sole and exclusive remedy of the holder of the notes will be to
unwind the MIPA transaction. The principal amount of the Notes, together with any and all accrued and unpaid interest thereon, will be
paid to on a monthly basis in an amount equal to the Monthly Free Cash Flow continuing thereafter on the twentieth (20 th )
calendar day of each calendar month thereafter. Monthly Free Cash Flow means cash proceeds received by SFD and WCCC from its operations
minus any capital expenditures (including, but not limited to, maintenance capital expenditures and expenditures for personal protective
equipment, additions to the land/current facilities and pipeline connections) and any payments on the lease obligations of SFD and WCCC.
Subsequent to September 30, 2022, we entered into an agreement amending the Notes, whereby, as soon as is practicable, following
and subject to the approval of our shareholders, and provided there are no applicable prohibitions under the rules of The Nasdaq Capital
Market or other restrictions, we will issue 7,042,254 restricted shares of our common stock as a payment of $10,000,000 toward the principal
of the Notes on a pro rata basis (the “Note Payment”), reflecting a conversion price of $1.42 per share. 6,971,831 shares
will be issued to Jorgan and $9,900,000 of principal owed to Jorgan will be cancelled and 70,423 shares will be issued to JBAH and $100,000
of principal owed to JBAH will be cancelled. Once a registration statement registering the shares for the Note Payment is declared effective
by the SEC, the Note Payment will count against the threshold payment amount, as defined in the notes and the MIPA. As of December 31,
2022 we have accrued interest of approximately $ 247,914 and made cash payments of $ 1,565,090 .
F- 45
In
the business combination of acquiring WCCC we also acquired WCCC’s Oil Storage Agreement with White Claw Crude, LLC (“WC
Crude”), who shares a beneficiary, James Ballengee, with Jorgan and JBAH. Under this agreement, WC Crude has the right, subject
to the payment of service and maintenance fees, to store volumes of crude oil and other liquid hydrocarbons at a certain crude oil terminal
operated by WCCC. WC Crude is required to pay $150,000 per month even if the storage space is not used. The agreement expires on December 31,
2031. Since acquiring this contract on August 1, 2022 we have received tank storage revenue of approximately $750,000.
In
the business combination of acquiring SFD, we acquired an amended Crude Petroleum Supply Agreement with WC Crude (the “Supply Agreement”),
under which WC Crude supplies volumes of Crude Petroleum to SFD, which provides for the delivery to SFD a minimum of 1,000 sourced barrels
per day, and includes a guarantee that when SFD resells these barrels, if SFD does not make at least a $5.00 per barrel margin on the
oil purchased from WC Crude, then WC Crude will pay to SFD the difference between the sales price and $5.00 per barrel. In the event
that SFD makes more than $5.00 per barrel, SFD will pay WC Crude a profit-sharing payment in the amount equal to 10% of the excess price
over $5.00 per barrel, which amount will be multiplied by the number of barrels associated with the sale. The Supply Agreement expires
on December 31, 2031. Since acquiring this contract on August 1, 2022 we have made crude oil purchases from WC Crude of $ 25,239,962 .
In addition, SFD entered into a sales
agreement on April 1, 2022 with WC Crude to sell a natural gas liquid product to WC Crude. SFD sells the NGL
stream at cost to WC Crude. We produced and sold natural gas liquids to WC Crude in the amount of $ 5,890,910 as of December 31, 2022.
In
the business combination of acquiring SFD and WCCC we also entered into a Shared Services Agreement with Endeavor Crude, LLC (“Endeavor”),
who shares a beneficiary, James Ballengee, with Jorgan and JBAH. Under this agreement, we have the right, but not the obligation to use
Endeavor for consulting services. Since entering into this contract on August 1, 2022, we have paid Endeavor $37,993.
In
September 2020, we entered into a consulting contract with LBL Professional Consulting, Inc. (“LBL”), of which our Chief
Financial Officer is also an officer, which remains in effect. For the twelve months ended December 31, 2022, LBL invoiced the Company
for $340,484. On December 17, 2020 the Company granted non-statutory stock options to LBL to purchase 333,334 shares of common stock,
which was cancelled on September 1, 2022 by the parties. Our Chief Financial Officer is not the beneficiary of the Company and is
not permitted to participate in any discussion, including LBL’s board meetings, regarding any Company stock that LBL may own at
any time.
We
have an existing note payable issued to Triple T, which is owned by Dr. Khalid Bin Jabor Al Thani, the 51% majority-owner of Vivakor
Middle East LLC The note is interest free, has no fixed maturity date and will be repaid from revenues generated by Vivakor Middle East
LLC. As of December 31, 2022 the balance owed was $ 342,830 .
On
January 20, 2021, we entered into a worldwide, exclusive license agreement with TBT Group, Inc. (of which an independent Vivakor
Board member at the time was a 7% shareholder of TBT Group, Inc.) to license piezo electric and energy harvesting technologies for creating self-powered sensors for
making smart roadways. We paid $25,000 and 16,667 shares of restricted common stock upon signing and $225,000 as of April 5, 2022.
When the licensor delivers to us data showing that the sensor performs based on mutually defined specifications and all designs for the
sensor are completed, we shall pay an additional $250,000 and 16,667 shares of restricted common stock. Upon the delivery of a mutually
agreed working prototype, we will pay licensor $250,000 and 16,667 shares of restricted common stock. Upon commercialization of the product,
we will pay licensor $250,000 and 33,333 shares of restricted common stock. TBT shall have the option, at its sole discretion, to convert
the license to a non-exclusive license if we fail to pay $500,000 to TBT for sensor inventory per year, which will commence after the
second anniversary of product commercialization. We shall share in the development costs of the sensor technology to the time of commercialization. From May 2021 through March 3, 2022, the parties amended the license
agreement to extend the terms of the first milestone to March 4, 2022, of which we paid $15,000 as consideration for the extensions
and $225,000 to be paid on March 4, 2022.
Note
24. Subsequent Events
The
Company has evaluated subsequent events through the date the financial statements were available to issue. Subsequent to
December 31, 2022, VWFI has extended the termination date of its $25M offering until March 31,
2023. VWFI has raised $1,980,000 in conjunction with the $25,000,000 private placement offering to sell
convertible promissory notes, which convert to VWFI LLC units, to accredited investors to raise funds to manufacture RPC Series B. Subsequent to December 31, 2022, VWFI has also converted $555,000 of convertible debt into VWFI LLC
units.
F- 46
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.